<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">107582</article-id><article-id pub-id-type="doi">10.7554/eLife.107582</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.107582.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>ATAD2 mediates chromatin-bound histone chaperone turnover</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liakopoulou</surname><given-names>Ariadni</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0005-8964-9205</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Boussouar</surname><given-names>Fayçal</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4529-4893</contrib-id><email>faycal.boussouar@univ-grenoble-alpes.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Perazza</surname><given-names>Daniel</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7703-4984</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Barral</surname><given-names>Sophie</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9915-6096</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Lambert</surname><given-names>Emeline</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0005-6909-5831</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Tao</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5178-6969</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Chuffart</surname><given-names>Florent</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6064-5183</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Bourova-Flin</surname><given-names>Ekaterina</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5673-9045</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Gard</surname><given-names>Charlyne</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Puthier</surname><given-names>Denis</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7240-5280</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Rousseaux</surname><given-names>Sophie</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5246-5350</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Arnoult</surname><given-names>Christophe</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3753-5901</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Verdel</surname><given-names>André</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6048-3794</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Khochbin</surname><given-names>Saadi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0455-0857</contrib-id><email>saadi.khochbin@univ-grenoble-alpes.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02rx3b187</institution-id><institution>Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences</institution></institution-wrap><addr-line><named-content content-type="city">Grenoble</named-content></addr-line><country>France</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035xkbk20</institution-id><institution>Aix-Marseille Université</institution></institution-wrap><addr-line><named-content content-type="city">Marseille</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Dalal</surname><given-names>Yamini</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040gcmg81</institution-id><institution>National Cancer Institute</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Dalal</surname><given-names>Yamini</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040gcmg81</institution-id><institution>National Cancer Institute</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>20</day><month>01</month><year>2026</year></pub-date><volume>14</volume><elocation-id>RP107582</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2025-05-23"><day>23</day><month>05</month><year>2025</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2025-05-27"><day>27</day><month>05</month><year>2025</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.10.04.616609"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-09-22"><day>22</day><month>09</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.107582.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2026-01-05"><day>05</day><month>01</month><year>2026</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.107582.2"/></event></pub-history><permissions><copyright-statement>© 2025, Liakopoulou et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Liakopoulou et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-107582-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-107582-figures-v1.pdf"/><abstract><p>ATAD2, a conserved protein which is predominantly expressed in embryonic stem (ES) cells and spermatogenic cells, emerges as a crucial regulator of chromatin plasticity. Our previous parallel studies conducted in both ES cells and <italic>S. pombe</italic> highlighted the fundamental role of ATAD2 in facilitating chromatin-bound histone chaperone turnover. Focusing on mouse spermatogenesis, we demonstrate here that ATAD2 regulates the HIRA-dependent localization of H3.3 on the genome and influences H3.3-mediated gene transcription. Moreover, by modulating histone eviction and the assembly of protamines, ATAD2 ensures proper chromatin condensation and genome packaging in mature sperm. Disruption of <italic>Atad2</italic> function in mice leads to abnormal genome organization in mature spermatozoa. Together, these findings establish a previously overlooked level of chromatin dynamic regulation, governed by ATAD2-controlled histone chaperones binding to chromatin, which defines the balance between histone deposition and removal.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>chromatin dynamics</kwd><kwd>Spermatogenesis</kwd><kwd>Atad2</kwd><kwd>chaperone turnover</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rbzpz17</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR EpiSperm 4 (ANR-19-CE12- 0014)</award-id><principal-award-recipient><name><surname>Khochbin</surname><given-names>Saadi</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rbzpz17</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR Episperm 5 (ANR-23-CE12-0028)</award-id><principal-award-recipient><name><surname>Khochbin</surname><given-names>Saadi</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rbzpz17</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR NME-CoA (ANR-23-CE14-0050)</award-id><principal-award-recipient><name><surname>Khochbin</surname><given-names>Saadi</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>ATAD2 orchestrates histone turnover during spermatogenesis, regulating H3.3 deposition, chromatin condensation, and genome packaging to ensure proper sperm genome organization and transcriptional control.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Spermatogenesis involves unique and dramatic chromatin remodeling and genome reorganization events that take place in preparation for a shift from the universal nucleosome-based eukaryotic genome organization into a unique nucleoprotamine-based structure (<xref ref-type="bibr" rid="bib16">Gaucher et al., 2010</xref>; <xref ref-type="bibr" rid="bib4">Bao and Bedford, 2016</xref>; <xref ref-type="bibr" rid="bib26">Le Blévec et al., 2020</xref>; <xref ref-type="bibr" rid="bib35">Okada, 2022</xref>). During the last decade, important information on the molecular basis of the nucleosome-to-nucleoprotamine transition during the postmeiotic phases of spermatogenesis became available. Several testis-specific H2A, H2B, and H3 histone variants replace the canonical histones, locally or globally, at different stages, starting early during the commitment of cells into meiotic and post-meiotic differentiation (<xref ref-type="bibr" rid="bib20">Hoghoughi et al., 2018</xref>). Most of this nucleosome dismantling and assembly occurs in the absence of DNA replication. In other words, the replication-independent nucleosome assembly pathways, such as the well-documented HIRA-dependent H3.3 assembly, are expected to be critical in ensuring the necessary chromatin remodeling in these cells. Finally, hints to the functions of transition proteins (TPs) and their functional relationship with protamines (PRMs) were proposed based on the study of a specific late-expressing H2A variant, H2A.L.2 (<xref ref-type="bibr" rid="bib6">Barral et al., 2017b</xref>). In the proposed model, we suggest that TPs do not directly replace histones, but rather could be loaded on open H2A.L.2-containing nucleosomes to control PRM assembly. Nucleosome-to-nucleoprotamine transition also includes a TP-dependent pre-PRM2 processing, histone displacement by PRMs and the structuration of the nucleoprotamine-based genome organization in the mature spermatozoa (<xref ref-type="bibr" rid="bib6">Barral et al., 2017b</xref>; <xref ref-type="bibr" rid="bib38">Rezaei-Gazik et al., 2022</xref>). In mice, two protamines, PRM1 and PRM2, replace histones. PRM2 is initially synthesized as a precursor protein, which undergoes sequential proteolytic processing at its N-terminal region during its incorporation, ultimately producing the mature, fully processed PRM2 (<xref ref-type="bibr" rid="bib3">Arévalo et al., 2022</xref>).</p><p>Taking into account this unique dynamic of post-meiotic cells’ nucleosomes, it is expected that these cells massively express generic factors, or those predominantly expressed in spermatogenic cells that act on chromatin, including histone acetylating machineries, acetylated histone readers, and histone variants and their chaperones, all of which mediate histone and non-histone protein exchanges. More specifically, the replication-independent nature of nucleosome assembly, both in cells undergoing meiosis and in post-meiotic cells, strongly suggests the involvement of the chaperone/histone substrate couple, HIRA and H3.3.</p><p>An important part of this replication-independent histone assembly and transitions in the genome organizations occurs in the context of a massive histone H4 hyperacetylation in the haploid spermatogenic cells, spermatids, mediated by NUT-p300/CBP histone acetyltransferase complex (<xref ref-type="bibr" rid="bib40">Shiota et al., 2018</xref>; <xref ref-type="bibr" rid="bib39">Rousseaux et al., 2022</xref>). Hyperacetylation of histone H4, especially the double acetylation on H4K5K8 in these cells, leads to the binding of H4 by the first bromodomain of BRDT and to histone replacement (<xref ref-type="bibr" rid="bib32">Morinière et al., 2009</xref>; <xref ref-type="bibr" rid="bib17">Gaucher et al., 2012</xref>; <xref ref-type="bibr" rid="bib18">Goudarzi et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Shiota et al., 2018</xref>). Additionally, histone H4 hyperacetylation, especially at K5, could also be recognized by another bromodomain-containing factor of unknown function in spermatogenic cells, ATAD2 (<xref ref-type="bibr" rid="bib9">Caron et al., 2010</xref>; <xref ref-type="bibr" rid="bib33">Morozumi et al., 2016</xref>).</p><p>ATAD2 is a highly conserved bromodomain-containing factor that also harbors an AAA+ATPase domain (<xref ref-type="bibr" rid="bib8">Boussouar et al., 2013</xref>; <xref ref-type="bibr" rid="bib10">Cattaneo et al., 2014</xref>). Our early work showed that <italic>Atad2</italic> is predominantly expressed in ES cells, as well as in spermatogenic cells, and is aberrantly activated in virtually all solid cancers (<xref ref-type="bibr" rid="bib9">Caron et al., 2010</xref>). Although ATAD2’s function in cancer prompted many investigations (<xref ref-type="bibr" rid="bib28">Liu et al., 2022</xref>), its function in its physiological context of expression has remained largely overlooked. We reported the first investigations of ATAD2’s function in ES cells (<xref ref-type="bibr" rid="bib33">Morozumi et al., 2016</xref>). These studies in ES cells showed that ATAD2 is recruited into acetylated transcriptionally active chromatin and is critical to keep the chromatin of ES cells highly dynamic, as illustrated by an ATAD2-dependent high rate of histone exchange (<xref ref-type="bibr" rid="bib33">Morozumi et al., 2016</xref>). Subsequent studies conducted by our laboratory, in ES cells and in <italic>S. pombe</italic>, deciphered the molecular basis of this activity of ATAD2, which relies on its capacity to ensure the turnover of the chromatin-bound histone chaperone, HIRA and FACT (<xref ref-type="bibr" rid="bib48">Wang et al., 2021</xref>). In addition to ES cells, <italic>Atad2</italic> is also highly expressed in male germ cells, pointing to its potential role in the regulation of HIRA-dependent H3.3 assembly in these cells, especially in post-meiotic cells. Indeed, previous published works have highlighted the important function of H3.3 assembly in meiotic and post-meiotic male genome programming (<xref ref-type="bibr" rid="bib46">van der Heijden et al., 2007</xref>; <xref ref-type="bibr" rid="bib49">Yuen et al., 2014</xref>; <xref ref-type="bibr" rid="bib43">Tang et al., 2015</xref>; <xref ref-type="bibr" rid="bib15">Fontaine et al., 2022</xref>). We therefore hypothesized that ATAD2-regulated HIRA-H3.3 activity would also be a critical player in the post-meiotic male genome reorganization, as HIRA has been shown to be essential post-fertilization (<xref ref-type="bibr" rid="bib27">Lin et al., 2014</xref>) and during oogenesis (<xref ref-type="bibr" rid="bib34">Nashun et al., 2015</xref>).</p><p>Using a lacZ tagged <italic>Atad2</italic> knockout (KO) mouse model, we could show that <italic>Atad2</italic>’s expression is enhanced in post-meiotic male germ cells, ensuring a proper turnover of histone H3.3, including on the sex chromosomes. More remarkably, our data demonstrate that ATAD2 controls the appropriate expression of a series of genes whose activity is known to be H3.3-dependent in post-meiotic cells. Additionally, in the absence of ATAD2, perturbed nucleosome structural organization leads to a delayed histone-to-PRM replacement, leading to a defective global final male genome compaction. Although this defect in mature spermatozoon genome compaction has minimal effect on male fertility during natural reproduction, it impacts the success rate of in vitro fertilization using spermatozoa from <italic>Atad2</italic> KO mice, pointing to a more fragile genome in these cells.</p><p>In summary, our work revealed a novel mechanism for the regulation of chromatin plasticity, involving the control of histone chaperone actions, particularly that of HIRA, controlling the proper male germ cell transcriptional regulation, genome compaction, and optimal male fertility.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Atad2 is predominantly expressed in haploid male germ cells</title><p><italic>Atad2</italic> is normally expressed in embryonic stem (ES) and spermatogenic cells and remains silent in the majority of adult tissues (<xref ref-type="bibr" rid="bib9">Caron et al., 2010</xref>; <xref ref-type="bibr" rid="bib33">Morozumi et al., 2016</xref>). Therefore, in addition to ES cells, male germ cells constitute the second cell type where the molecular basis of the physiological ATAD2 activity could be investigated.</p><p>To decipher the function of ATAD2 during spermatogenesis, we used a mouse model harboring an insertion of a <italic>lacZ</italic> reporter cassette between exons 11 and 12 that enables splicing and fusion of the <italic>lacZ</italic> transgene with exon 11 of the long and short forms of <italic>Atad2</italic> (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) and production of a non-functional ATAD2-lacZ fusion protein (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), referred to as <italic>Atad2</italic> KO in this study. Furthermore, we crossed these mice with transgenic mice expressing ubiquitously Cre recombinase under <italic>CMV</italic> promoter, in order to remove the <italic>neo</italic> cassette and to delete <italic>Atad2’s</italic> exon 12 (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). In addition to the long somatic form of ATAD2, ATAD2L, the mouse testis encodes a short isoform with predominant expression in spermatogenic cells that we previously named ATAD2S (<xref ref-type="bibr" rid="bib9">Caron et al., 2010</xref>). The combined LacZ fusion and <italic>Cre recombinase-</italic>dependent deletion of <italic>Atad2’s</italic> exon 12 makes both ATAD2L and ATAD2S indetectable with our homemade antibody, while, as expected, a reduced level of both ATAD2 isoforms in <italic>Atad2</italic> heterozygous cells can be observed (<xref ref-type="fig" rid="fig1">Figure 1C</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>Atad2</italic> is highly expressed in post-meiotic male germ cells.</title><p>(<bold>A</bold>) The exon/intron organization of <italic>Atad2</italic> gene and the two ATAD2-encoding transcriptional units (encoding for ATAD2-long and ATAD2-short) are indicated (<xref ref-type="bibr" rid="bib13">Dyer et al., 2025</xref>). The red arrows indicate the position of insertion of the <italic>Lac-Z-Lox-Neo-Lox</italic> cassette. (<bold>B</bold>) Gene targeting strategy for the generation of the <italic>Atad2</italic> KO allele is represented. Exon number and relative position, selection gene cassettes, LoxP sites, and Frt sites are indicated. Crossing mice bearing this construct with <italic>CMV-Cre</italic> mice resulted in the generation of the <italic>Atad2 Lac Z<sup>ΔNeo-Exon12</sup></italic> allele, which can be verified through PCR amplification of the genomic DNA (shown on the ethidium bromide-stained gel). The expected amplified bands for each genotype allowing the detection of both wild-type and KO alleles of <italic>Atad2</italic> are indicated. E=Exon. (<bold>C</bold>) Total protein extracts from wild-type (WT), heterozygous (HET) and <italic>Atad2</italic> homozygous knockout (KO) mice testes were probed with anti-ATAD2 and anti-H3 antibodies as indicated. Four different mice were used for this experiment. (<bold>D</bold>) Seminiferous tubule sections from wild-type and <italic>Atad2</italic> KO mice were stained with X-gal to visualize <italic>lacZ</italic> gene expression and β -galactosidase activity under the endogenous <italic>Atad2</italic> gene promoter. Testes from three different wild-type and <italic>Atad2</italic> KO mice were used to generate the represented sections. Scale bar: 200 μm.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig1">Figure 1C</xref>, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107582-fig1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig1">Figure 1C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107582-fig1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107582-fig1-v1.tif"/></fig><p>The expression of <italic>lacZ</italic> under the control of the <italic>Atad2</italic> promoter allows one to visualize <italic>Atad2</italic> gene activity in a stage-specific manner. X-gal staining of seminiferous tubule sections from <italic>Atad2</italic> KO mice showed a remarkably high expression of <italic>Atad2</italic> in post-meiotic spermatogenic cells (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). It is noteworthy that, as expected, no staining was observed in the wild-type tubules.</p></sec><sec id="s2-2"><title>ATAD2 controls HIRA accumulation</title><p>In our previous work performed in both <italic>S. pombe</italic> and mouse ES cells, we demonstrated the crucial role for ATAD2 in HIRA-dependent histone dosage as well as in HIRA-chromatin interaction. Among other discoveries, this work showed that in the absence of ATAD2, HIRA becomes trapped on chromatin leading to its accumulation in ES cells, as well as in a variety of cancer cell lines (<xref ref-type="bibr" rid="bib48">Wang et al., 2021</xref>). Because of this very conserved action of ATAD2 in controlling the HIRA activity, we reasoned that the ATAD2-dependent HIRA activity should be particularly active during spermatogenic cell differentiation, especially in post-meiotic cells, when ATAD2 expression is highly induced (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). To test if the absence of ATAD2 could lead to the accumulation of HIRA, as we previously reported in other systems, we quantified HIRA in spermatogenic cells from both wild-type and <italic>Atad2</italic> KO mice. These investigations revealed an accumulation of HIRA protein in <italic>Atad2</italic> KO spermatogenic cells (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), consistent with its increased association with chromatin (<xref ref-type="bibr" rid="bib48">Wang et al., 2021</xref>). We have also monitored HIRA accumulation as a function of spermatogenic cell stages. Due to the strong activation of <italic>Atad2</italic> after meiosis in spermatids (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), the ATAD2-dependent accumulation of HIRA was expected to mostly occur in post-meiotic cells. Accordingly, we also compared HIRA accumulation in fractionated spermatogenic cell extracts. This experiment demonstrated that, in the absence of functional ATAD2, the accumulation of HIRA primarily occurs in round spermatids (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). This finding is consistent with the post-meiotic activation of Atad2 and its role in regulating the turnover of chromatin-bound HIRA.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Atad2</italic> gene inactivation leads to the accumulation of HIRA.</title><p>(<bold>A</bold>) Total protein extracts from the testes of five wild-type (WT) and five <italic>Atad2</italic> KO mice were used to detect HIRA and H3 by immunoblotting. The panel shows a representative immunoblotting after HIRA detection. The histogram in the right panel shows the quantification of HIRA immunoblotting signal normalized to H3. The mean ± standard deviation was 0.86±0.21 for wild type and 1.15±0.06 for <italic>Atad2</italic> KO samples. The <italic>P</italic> value was 0.02 for unpaired Student <italic>t</italic>-test. (<bold>B</bold>) Protein extracts from fractionated spermatogenic cells from wild-type (<italic>Atad2</italic> WT) and knockout (<italic>Atad2</italic> KO) mice (pool of testes from three individuals per genotype) were used to detect HIRA and H3 by immunoblotting.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig2">Figure 2A</xref>, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107582-fig2-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig2">Figure 2A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107582-fig2-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig2">Figure 2B</xref>, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107582-fig2-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig2sdata4"><label>Figure 2—source data 4.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig2">Figure 2B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107582-fig2-data4-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107582-fig2-v1.tif"/></fig></sec><sec id="s2-3"><title>ATAD2 controls HIRA-dependent H3.3 localization</title><p>We speculated that an increased presence of HIRA on chromatin in the absence of ATAD2 should also be associated with increased amounts of deposited histones. Indeed, we have demonstrated previously in <italic>S. pombe</italic> that histone gene inactivation could rescue the growth arrest due to the absence of <italic>Atad2</italic>/<italic>Abo1</italic>. In parallel, we found that in ES cells, in the absence of ATAD2, an increased nucleosome assembly occurs, even on the so-called nucleosome-free region (NFR) (<xref ref-type="bibr" rid="bib48">Wang et al., 2021</xref>).</p><p>Interestingly, visualization of H3.3, the major target of HIRA, by immunofluorescence, in <italic>Atad2</italic> KO round spermatids, displayed a diffuse staining with local concentration (<xref ref-type="fig" rid="fig3">Figure 3</xref>). H3.3 is normally concentrated on the sex chromosomes (<xref ref-type="bibr" rid="bib46">van der Heijden et al., 2007</xref>; <xref ref-type="bibr" rid="bib15">Fontaine et al., 2022</xref>) in the wild-type cells. Indeed, as expected and previously reported, in the wild-type round spermatids, H3.3 was mostly observed in a single domain, close to the unique chromocenter in these cells (<xref ref-type="fig" rid="fig3">Figure 3</xref>, left panels). In the absence of ATAD2, in agreement with an increased residence time of HIRA on chromatin in general and a reduced H3.3 turnover, an increased level of H3.3 could be observed on the sex chromosome (adjacent to the chromocenter), and more interestingly, on all over the genome (<xref ref-type="fig" rid="fig3">Figure 3</xref>, right panels).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Enhanced H3.3 detection in <italic>Atad2</italic> KO post-meiotic cells.</title><p>A specific antibody against H3.3 was used to detect H3.3 in round spermatid cells from wild-type (<italic>Atad2</italic> WT) and knockout (<italic>Atad2</italic> KO) mice. Round spermatids are recognizable by their distinctive Hoechst-bright chromocenter (upper panels). The lower panels represent a higher magnification of selected cells that are displayed at lower magnification in the upper panels. The images show H3.3 labeling and Hoechst staining alone or the merged images of these staining as indicated. The nuclear boundaries defined by Hoechst staining are outlined by white lines.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107582-fig3-v1.tif"/></fig></sec><sec id="s2-4"><title>General chromatin accessibility and transcriptional regulation by ATAD2</title><p>H3.3 is known to be dynamically incorporated on a group of active genes, especially around their transcriptional start sites (TSS) (<xref ref-type="bibr" rid="bib11">de Dieuleveult et al., 2016</xref>). We therefore predicted that the observed increased H3.3 residence time in the absence of ATAD2 would decrease TSS regions’ accessibility, especially those of highly active genes. To verify this prediction, we purified round spermatid fractions from wild-type and <italic>Atad2 KO</italic> mice testes and measured the general chromatin accessibility following an ATAC-seq approach. Chromatin accessibility was then assessed around the TSS of genes, which were categorized into four groups based on the quartile of their mean expression from three independent transcriptomes of wild-type round spermatids (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), from the top 25% most highly expressed genes (group 1) to the 25% least expressed genes (group 4). As predicted, the absence of ATAD2 was associated with a significant decrease in TSS region accessibility of the most active genes (<xref ref-type="fig" rid="fig4">Figure 4B and C</xref>), supporting a role for ATAD2 in maintaining chromatin dynamics at the most highly active chromatin regions.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>ATAD2 controls active gene TSS accessibility.</title><p>(<bold>A</bold>) Gene selection according to expression in wild-type round spermatids. The plot displays the mean expression levels (y-axis, labeled as &quot;mean expression level&quot;) versus the corresponding standard deviations (x-axis), both calculated from three independent biological replicates of isolated round spermatids. The standard deviation reflects the variability of gene expression across biological replicates. Genes were grouped into four categories (Group 1: blue, Group 2: cyan, Group 3: green, Group 4: orange) according to the quartile of their mean expression. For Group 4, all genes have no detectable expression, resulting in a mean expression of zero and a standard deviation of zero; consequently, the 5611 genes in this group are represented by a single overlapping point (red open circle) at the origin. (<bold>B</bold>) Heatmap on ATAC-seq signal. The heatmap shows the ATAC-seq signal of each group (Group 1 in blue, Group 2 in cyan, Group 3 in green, and Group 4 in orange) in rows, for 4 <italic>Atad2</italic> WT and 4 <italic>Atad2</italic> KO samples in columns. (<bold>C</bold>) Profiles according to selected genes. The mean profiles are displayed together with their variability (±2 s.e.m.) across the four replicates for both <italic>Atad2</italic> WT (blue) and <italic>Atad2</italic> KO (red). For groups 1, 2, and 3, the envelopes of the curves remain clearly separated around the peak, indicating a consistent difference in signal between the two conditions. In contrast, group 4 does not present a strong signal and, accordingly, no marked difference is observed between <italic>Atad2</italic> WT and KO in this group.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107582-fig4-v1.tif"/></fig><p>To visualize the genes more sensitive to ATAD2-mediated chromatin remodeling that affect transcription, we monitored whole genome transcriptional activity during the first spermatogenic wave at day 20 post-partum (PP), when meiosis is complete, and in the first post-meiotic cells that appear on 22, 24, and 26 days PP.</p><p>In order to definitively confirm our working hypothesis on the ATAD2-HIRA-H3.3 functional interaction, we took advantage of published H3.3-dependent transcriptomic data (<xref ref-type="bibr" rid="bib15">Fontaine et al., 2022</xref>). Indeed, the authors of this publication identified a series of genes that are misregulated in cells with inactivated <italic>H3.3b</italic> gene. H3.3 is encoded by two distinct genes, <italic>H3f3a</italic> and <italic>H3f3b</italic>, which are located on different chromosomes and display distinct genomic organization, yet produce proteins with identical amino acid sequences (<xref ref-type="bibr" rid="bib23">Krimer et al., 1993</xref>). Because of the post-meiotic major activation of <italic>Atad2</italic>, we specifically focused on the gene lists that show a H3.3-dependent deregulated expression in post-meiotic round spermatids.</p><p>In these transcriptomes, we specifically followed the expression of the published lists of genes that are downregulated or upregulated in the absence of H3.3 (<xref ref-type="bibr" rid="bib15">Fontaine et al., 2022</xref>). Very interestingly, we observed that a significant number of genes (37%) that were reported to be down-regulated in the absence of H3.3 (H3.3-activated genes) are upregulated in the absence of ATAD2, particularly at day 26 PP, when post-meiotic cells are present in the testes (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). Gene Set Enrichment Analysis (GSEA) applied to genes that are differentially expressed between wild-type and <italic>Atad2</italic> KO cells at day 26 PP confirmed that the ‘H3.3-activated‘ gene set (corresponding to the published list of H3.3-activated genes) is clearly enriched in <italic>Atad2</italic> KO cells (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, right panel).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>ATAD2 enhances H3.3 gene regulatory functions.</title><p>(<bold>A</bold>) Expression profiles of post-meiotic H3.3-activated genes. The heatmap (left panel) displays the normalized expression levels of genes identified by Fontaine and colleagues as upregulated in the absence of histone H3.3 (<xref ref-type="bibr" rid="bib15">Fontaine et al., 2022</xref>) for <italic>Atad2</italic> WT (WT) and <italic>Atad2</italic> KO (KO) samples at days 20, 22, 24, and 26 PP (D20 to D26). The color scale represents the z-score of log-transformed DESeq2-normalized counts. The middle panel box plots display pooled, normalized expression levels, aggregated across replicates and genes, for each condition (WT and KO) and each time point (D20 to D26). Statistical significance between WT and KO conditions was determined using a two-sided <italic>t</italic>-test, with p-values indicated as follows: * for <italic>P</italic>-value &lt;0.05, ** for <italic>P</italic>-value &lt;0.01 and *** for <italic>P</italic>-value &lt;0.001. The right panel shows the results of gene set enrichment analysis (GSEA), which assesses whether predefined groups of genes show statistically significant differences between conditions. Here, the post-meiotic H3.3-activated genes set, identified by <xref ref-type="bibr" rid="bib15">Fontaine et al., 2022</xref>, is significantly enriched in <italic>Atad2</italic> KO compared with WT samples at day 26 (<italic>P</italic>&lt;0.05, FDR &lt;0.25). Colored vertical bars indicate the “leading edge” genes (i.e., those contributing most to the enrichment signal), located before the point of maximum enrichment score. (<bold>B</bold>) As shown in (<bold>A</bold>) but for the &quot;post-meiotic H3.3-repressed genes&quot; gene set. (<bold>C</bold>) As shown in (<bold>A</bold>) but for the &quot; sex chromosome-linked genes &quot; gene set.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107582-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Venn diagrams showing the overlap of significantly differentially expressed genes between <italic>Atad2</italic> KO and <italic>Atad2</italic> WT samples at day 26 post-partum (PP), compared with three gene sets reported by <xref ref-type="bibr" rid="bib15">Fontaine et al., 2022</xref>.</title><p>(<bold>A</bold>) Genes upregulated in the absence of histone H3.3 in both <italic>Atad2</italic> WT and <italic>Atad2</italic> KO samples at day 26 PP. (<bold>B</bold>) Genes repressed under the same conditions, and (<bold>C</bold>) sex chromosome–linked genes. In the differential expression analysis, a fold change greater than 1.2 between <italic>Atad2</italic> KO and <italic>Atad2</italic> WT samples was considered significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107582-fig5-figsupp1-v1.tif"/></fig></fig-group><p>This regulation can also be observed when we considered the published list of genes that were up-regulated in the absence of H3.3 (H3.3-repressed genes). In this case, the absence of ATAD2 led to the enhancement of the down-regulation of these genes (37%). In other words, the absence of ATAD2 led to an enhancement of H3.3-dependent gene repression (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>).</p><p>Fontaine and colleagues also reported that sex chromosome-linked genes that normally undergo Meiotic Sex Chromosome Inactivation (MSCI) were up-regulated in the absence of H3.3, indicating that H3.3 is required for their repression. We also investigated these genes and showed that they present an enhancement of repression in the absence of ATAD2 (51%) (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>).</p><p>These analyses clearly indicate that the absence of ATAD2 enhances H3.3 functions in agreement with increased residence time of H3.3 in nucleosomes. Genes that require H3.3 to be repressed or activated present an enhanced repression or activation, respectively, in the absence of ATAD2.</p><p>Overall, these investigations remarkably confirmed a role for ATAD2 in regulating H3.3 function.</p></sec><sec id="s2-5"><title>ATAD2 is required for controlled histone eviction and PRM assembly</title><p>ATAD2’s involvement in HIRA-chromatin interaction mobility and its role in H3.3 assembly in post-meiotic cells, along with its similar function in the control of other histone chaperones like FACT (<xref ref-type="bibr" rid="bib48">Wang et al., 2021</xref>), led us to investigate whether ATAD2 participates in controlling the histone-to-protamine replacement that occurs later in these cells. The histone eviction process involves a genome-wide histone H4 hyperacetylation (<xref ref-type="bibr" rid="bib40">Shiota et al., 2018</xref>) and a TP-mediated PRMs assembly, which directs histone eviction and the final packaging of the male genome (<xref ref-type="bibr" rid="bib5">Barral et al., 2017a</xref>). To test the involvement of ATAD2 in spermatogenic cell chromatin reorganization, we sought to co-detect testis-specific H2B variant, TH2B (<xref ref-type="bibr" rid="bib30">Montellier et al., 2013</xref>), along with transition protein 1 (TP1) and protamine 1 (PRM1). TH2B is first expressed at the commitment of spermatogenic cells into meiotic divisions and progressively becomes the major H2B species of spermatogenic cell chromatin in the subsequent stages (<xref ref-type="bibr" rid="bib30">Montellier et al., 2013</xref>). As expected, the accumulation of TP1 and PRM1 in wild-type cells is associated with the eviction of the majority of histones, reflected by the mutually exclusive labeling of TH2B and TP1/PRM1 in distinct cells (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>, <italic>Atad2</italic> wild-type mice). In contrast, in <italic>Atad2</italic> KO cells, TH2B and TP1/PRM1 were co-detected in a significant number of cells (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>), suggesting that the process of histone eviction is disturbed. However, in <italic>Atad2</italic> KO cells, the initial delay in histone removal is transient, as spermatids with high levels of transition protein TP1 and PRM1 eventually appear (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>ATAD2 is required for efficient histone-to-protamine replacement.</title><p>(<bold>A</bold>) Spermatogenic cell preparations from wild-type and <italic>Atad2</italic> KO mice were stained with antibodies against TH2B (in green) and transition protein 1 (TP1) or protamine 1 (PRM1) (in red). A yellow signal indicates the co-detection of TH2B along with TP1 or PRM1. The indicated fields are shown at higher magnification in panel “B”. Scale bar: 10 μm. (<bold>B</bold>) Fields shown in panel “A” are ordered to illustrate the transition from the histone-associated genome to its packaging by protamines, considering both wild-type and <italic>Atad2</italic> KO spermatogenic cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107582-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title><italic>Atad2</italic> gene inactivation does not disrupt testis morphology, acetylation of H4K5, or the cell-specific accumulation of H2A.L.2, TP2, PRM1, and PRM2.</title><p>Paraffin-embedded sections from wild-type or <italic>Atad2</italic> KO testes were used to visualize the accumulation of H4K5ac or expression of H2A.L.2, TP2, PRM1, and PRM2.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107582-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title><italic>Atad2</italic> depletion affects testis weight and mature sperm counts.</title><p>(<bold>A</bold>) Testes from six 21- to 27-week-old wild-type and <italic>Atad2</italic> KO mice were collected, weighted (mg), and their weights normalized to body weight and only same-age mice were compared pairwise. Histograms represent the mean of the measured weights and error bars the Standard Deviation (upper panel). The <italic>p-</italic>value of pairwise Student <italic>t</italic>-test=0.004. The lower panel shows representative testes from wild-type and <italic>Atad2</italic> KO mice. (<bold>B</bold>) Spermatozoa count (Cells/mL) was performed for pairs of wild type and <italic>Atad2</italic> KO (n=<italic>6</italic>). The average numbers of spermatozoa counts are respectively 21.6±5.8 and 13.7±4, and the <italic>P-</italic>value of paired Student <italic>t</italic>-test=0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107582-fig6-figsupp2-v1.tif"/></fig></fig-group><p>These observations strongly suggest that, in the absence of ATAD2, the process of histone eviction is also slowed down or delayed, allowing for the simultaneous detection of histones and histone-replacing proteins in the same cells.</p><p>Given that NUT-CBP/p300-dependent H4 hyperacetylation, along with the expression of H2A.L.2, TPs, and PRMs, is essential for histone removal, we also investigated whether the observed delay in histone removal is due to defective histone acetylation, particularly at H4K5, as well as disrupted cell type-specific expression and localization of H2A.L.2, TPs, and PRMs. Immunohistochemical detection of H4K5ac, H2A.L.2, TP2, PRM1, and PRM2 revealed a similar pattern and cell type-specific expression of the investigated proteins when comparing <italic>Atad2</italic> KO and wild-type post-meiotic cells. (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>).</p><p>These data support the idea that the perturbed modified flexibility of histone/TP/PRM chaperones does not grossly affect the other molecular events involved in the histone-to-PRM replacement.</p></sec><sec id="s2-6"><title>Perturbed pre-PRM2 processing in the absence of ATAD2</title><p>We have shown previously that the H2A.L.2-dependent process of incorporation of TPs into nucleosomes is required for the proper processing of pre-PRM2. The abnormal overlapping staining of histones, TP, and protamines observed by immunofluorescence in <italic>Atad2</italic> KO cells suggested that TPs may not effectively mediate the pre-PRM processing. To test this hypothesis, we took advantage of our specific pre-PRM2 antibody (<xref ref-type="bibr" rid="bib38">Rezaei-Gazik et al., 2022</xref>) to investigate pre-PRM2 maturation and assembly. <xref ref-type="fig" rid="fig7">Figure 7A</xref> shows that although pre-PRM2 is present in both wild-type and <italic>Atad2</italic> KO elongating spermatids, in the absence of ATAD2, pre-PRM2 tends to form dense aggregates as well as fragmented genomic domains. This phenomenon is also associated with an increased accumulation of pre-PRM2 protein level in testis extracts of <italic>Atad2</italic> KO spermatogenic cells compared to wild-type cells as revealed by ELISA and immunoblotting (<xref ref-type="fig" rid="fig7">Figure 7B</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>ATAD2 is required for proper pre-protamine 2 processing and protamine assembly.</title><p>(<bold>A</bold>) A specific antibody raised against the processed part of pre-PRM2 (<xref ref-type="bibr" rid="bib38">Rezaei-Gazik et al., 2022</xref>) was used to detect pre-PRM2 expression and localization in tubular elongating spermatid cells. The lower panels represent the magnification of selected cells. (<bold>B</bold>) The amount of pre-PRM2 was detected using soluble extracts from testis of wild-type and <italic>Atad2</italic> KO mice using ELISA. Histograms show the normalized values (pre-PRM2/tubulin) of 4 measurements of independent sedimentation samples of Elongating/Condensing fractions. Mean ± Standard Deviation is 1.6±0.2 and 2.1±0.1 for wild type and <italic>Atad2</italic> KO samples, respectively. The p-value obtained using an unpaired Student’s <italic>t</italic>-test was 0.0158.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107582-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>ATAD2 is required for proper pre-protamine 2 processing.</title><p>Extracts from representative samples shown in <xref ref-type="fig" rid="fig7">Figure 7B</xref>, derived from wild-type or <italic>Atad2</italic> knockout cells, were analyzed by SDS–PAGE followed by immunoblotting with anti-prePRM2 and anti-histone H3 antibodies (both probed on the same blot). The developed film was aligned with the corresponding blot and photographed. M, molecular weight marker.</p><p><supplementary-material id="fig7s1sdata1"><label>Figure 7—figure supplement 1—source data 1.</label><caption><title>PDF file containing original western blots for <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>, indicating the relevant bands.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107582-fig7-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig7s1sdata2"><label>Figure 7—figure supplement 1—source data 2.</label><caption><title>Original files for western blot analysis displayed in <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-107582-fig7-figsupp1-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107582-fig7-figsupp1-v1.tif"/></fig></fig-group><p>These data provide strong evidence that ATAD2 is required to streamline the activity of histone chaperones as well as other factors involved in histone exchange and TP/PRM assembly.</p></sec><sec id="s2-7"><title>Defective mature spermatozoa genome organization and male fertility in vitro</title><p>We show that although the <italic>Atad2</italic> KO post-meiotic cells’ defective chromatin organization does not affect the testis histology (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref> and <bold>data not shown</bold>), it impairs testis weight and sperm count, which are significantly reduced in <italic>Atad2</italic> KO mice (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>).</p><p>As expected, the impact of ATAD2 on HIRA function and TP/PRM assembly also has an impact on proper sperm genome compaction. Indeed, mature sperm genome decompaction test based on the incubation of sperm heads with heparin and the reducing agent DTT revealed a significant difference in the ability of the genome to resist genome decompaction conditions between wild-type <italic>Atad2</italic> and <italic>Atad2</italic> KO spermatozoa (<xref ref-type="fig" rid="fig8">Figure 8A</xref>; <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>). Given that spermatozoa with defective genome compaction are known to have poor success rate in in vitro fertilization (<xref ref-type="bibr" rid="bib7">Bashiri et al., 2021</xref>), we expected that spermatozoa from <italic>Atad2</italic> KO mice would perform worse in in vitro fertilization assays compared to wild-type spermatozoa. <xref ref-type="fig" rid="fig8">Figure 8B</xref> shows that this is, in fact, the case. However, surprisingly, fertility tests carried out on sexually mature adult males revealed that <italic>Atad2</italic> KO male mice are fertile, with only a statistically non-significant effect observed on their ability to foster pups (<xref ref-type="fig" rid="fig8">Figure 8C</xref>), indicating that in vivo fertilization could buffer a relatively large series of sperm genome compaction defaults.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>ATAD2s’ function in sperm genome compaction and fertility parameters.</title><p>(<bold>A</bold>) Epididymal sperm cells were isolated by the swim-up method from wild-type or <italic>Atad2</italic> KO mice and underwent a decompaction test and the sizes of the sperm heads were measured and represented as box plots (n=75 sperm heads / box plot). The value ranges (mean) were 10.4~19.3 (16.0) for wild type sperms without decompaction; 11.4~20.1 (16.4) for <italic>Atad2</italic> KO sperms without decompaction; 33.4~61.8 (48.5) for wild type sperms after decompaction; 45.0~78.9 (62.6) <italic>Atad2</italic> KO sperms after decompaction. Tukey’s HSD post two-way ANOVA test was used. ****<italic>P</italic>&lt;0.001. (<bold>B</bold>) Pools of oocytes from C57BL6 females were obtained and used for in vitro fertilization (IVF) with spermatozoa from WT or <italic>Atad2</italic> KO males (the experiment was repeated 4 times independently). The fertilization success rate is indicated as a percentage of oocytes giving rise to stage 2 embryos. Mean ± Standard Deviation is 25.5±14 and 12±5.2 for wild type and <italic>Atad2</italic> KO experiments, respectively, and the <italic>P</italic>=0.002 for ratio paired Student <italic>t</italic>-test. (<bold>C</bold>) Five wild-type and five <italic>Atad2</italic> KO male mice were each mated with two C57BL6 females, the resulting litter sizes were recorded and represented as box plots (n=28 and 30, respectively). The average numbers of pups are respectively 8.0±2.1 and 7.1±2.5 and the <italic>P-value of</italic> Student <italic>t</italic>-test=0.1.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107582-fig8-v1.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Sperm head decompaction after DTT and heparin treatment in wild-type and Atad2 KO males.</title><p>Epididymal sperm were treated with a DTT/heparin/Triton mixture, fixed, and stained with DAPI. Fluorescent images were acquired using a 63×oil-immersion objective, and sperm head size was quantified with ImageJ. Scale bars represent 5 μm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107582-fig8-figsupp1-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Taking advantage of the very conserved structural features of ATAD2 and relying on the power of yeast genetics, we previously discovered that ATAD2’s function is mostly to control major histone chaperone functions. Using a screen of the Abo1/ATAD2-dependent arrest of <italic>S. pombe</italic> cell growth, we found that impressively, 11 of the 14-growth arrest suppressor strains that we isolated impacted histone chaperones or histones themselves, with 8 distinct inactivating mutations in the histone chaperone HIRA complex. Furthermore, investigation of ATAD2-depleted mouse ES cells showed that HIRA accumulates and remains bound to nucleosomes, leading to nucleosome overloading around active gene TSSs and on the normally nucleosome-free regions (NFRs) of these genes.</p><p>Here, we showed that <italic>Atad2</italic> is highly expressed in post-meiotic spermatogenic cells and that in its absence, as in ES cells and in different cancer cells, HIRA accumulates. Our new data suggest that in the absence of ATAD2 activity, HIRA residency time on chromatin increases, leading to decreased turnover and overloading of its substrate, the histone variant H3.3 (<xref ref-type="fig" rid="fig9">Figure 9</xref>). This replication-independent histone has been first shown to assemble on the transcriptionally inactive meiotic cell sex chromosomes by Peter de Boer’s laboratory (<xref ref-type="bibr" rid="bib46">van der Heijden et al., 2007</xref>). Subsequent studies showed that H3.3 remained enriched on the sex chromosomes also in early post-meiotic cells, usually localized close to the unique large chromocenter in these cells (<xref ref-type="bibr" rid="bib15">Fontaine et al., 2022</xref>).</p><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>A model summarizing the role of ATAD2 in regulating chromatin-bound HIRA dynamics (along with other histone and non-histone protein chaperones) during the post-meiotic stages of mouse spermatogenesis.</title><p>Following the deposition of H3.3 by HIRA onto chromatin, ATAD2 facilitates the release of HIRA. In the absence of ATAD2, both HIRA and the newly incorporated H3.3 persist longer in nucleosomes. The scheme was created using BioRender (<ext-link ext-link-type="uri" xlink:href="https://BioRender.com/Cmcjckk">https://BioRender.com/Cmcjckk</ext-link>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-107582-fig9-v1.tif"/></fig><p>In agreement with the proposed role for ATAD2 in the control of HIRA-dependent dynamics of H3.3, we observed a more intense labeling of H3.3 on the sex bodies in round spermatids and, impressively, an increase in the genomic background detection of H3.3 in these cells.</p><p>The role of ATAD2 in the HIRA/H3.3 functions is further supported by comparing the reported H3.3-dependent transcriptome with the ATAD2-dependent transcriptome identified here.</p><p>Indeed, in the absence of ATAD2, we observed an enhancement of H3.3-dependent gene regulatory events (activation or repression), in agreement with an increased H3.3 presence and hence function, in the chromatin of <italic>Atad2</italic> KO post-meiotic cells.</p><p>These investigations on ATAD2’s role in post-meiotic spermatogenic cells built upon our previous findings in <italic>S. pombe</italic> and ES cells, uncover an additional level of regulation of histone turnover, which relies on the modulation of histone chaperone–chromatin interactions. Previously, A. Groth’s laboratory discovered that the histone chaperone DNAJC9 recruits the ATPase HSP70 to provide the necessary energy to release the chaperone from chromatin (<xref ref-type="bibr" rid="bib19">Hammond et al., 2021</xref>). Considering our data on the role of the ATPase ATAD2 with respect to HIRA and that of HSP70 with respect to DNAJC9, it is tempting to propose that ATP energy is required for the proper function of histone chaperones in controlling histone turnover.</p><p>Interestingly, very recently, the Song laboratory demonstrated that the <italic>S. pombe</italic> Abo1/ATAD2 is required for ATP-dependent dissociation of the histone chaperone FACT from chromatin, particularly at TSSs (<xref ref-type="bibr" rid="bib21">Jang et al., 2024</xref>). In line with this conclusion, ChIP-seq mapping of FACT in ATAD2-depleted ES cells revealed an accumulation of nucleosome-bound FACT at the TSSs of active genes (<xref ref-type="bibr" rid="bib48">Wang et al., 2021</xref>), supporting the idea that ATAD2 not only regulates the dynamics of histone-bound HIRA but also that of other histone chaperones such as FACT.</p><p>In addition to histones, many chromatin-bound regulatory factors also need to dynamically interact with chromatin, and hence ATAD2 could also be involved in mediating the dynamic interactions of such chromatin-bound factors. In agreement with this hypothesis, using proteomics of ATAD2-bound nucleosomes in ES cells, we previously co-purified various chromatin-bound factors (<xref ref-type="bibr" rid="bib33">Morozumi et al., 2016</xref>). Other AAA+ATPase factors, such as p97/VCP, have also been implicated in the remodeling of chromatin-bound factors. Indeed, the AAA+ATPase factor, p97/VCP, has been shown to remove H3 variant CENP-A (<xref ref-type="bibr" rid="bib44">van den Berg et al., 2023</xref>), the chromatin trapped PARP1 (<xref ref-type="bibr" rid="bib22">Krastev et al., 2022</xref>), trapped Ku70/80 (<xref ref-type="bibr" rid="bib45">van den Boom et al., 2016</xref>), DNA damage sensors, DDB2 and XPC (<xref ref-type="bibr" rid="bib36">Puumalainen et al., 2014</xref>), RNA pol II (<xref ref-type="bibr" rid="bib24">Lafon et al., 2015</xref>), and other chromatin interacting factors. Similarly, ATAD2 AAA+ATPase very likely acts on other chromatin-bound factors than histone chaperones. However, in contrast to p97/VCP, and due to its bromodomain, ATAD2 would preferentially act on H4K5 acetylated chromatin regions and would specifically ensure the dynamics of H4 acetylated chromatin-bound factors. Based on the data presented here, we can also include a role for ATAD2 to streamline steps involving the H2A.L.2-dependent recruitment of TPs and protamine assembly and the final histone displacement in spermatids. The chaperones responsible for TP/PRM assembly are not yet identified, but it is possible that ATAD2 plays a role in dissociating these chaperones from their substrate proteins after the assembly process. That is why in our <italic>Atad2</italic> KO spermatids, we observed an overlap between TP/PRM and histones. This could be due to the delayed removal of chaperones bound to TPs and PRMs and the inability of pre-PRM2 to be processed and hence of PRMs to efficiently replace histones. Since histone replacement still occurs in the absence of ATAD2, it suggests that other AAA+ATPases, such as p97/VCP, may compensate for its function. However, under these conditions, although most of the histone replacement takes place, our functional tests such as in vitro chromatin decompaction and in vitro fertilization strongly suggest that mature spermatozoa genome organization is not fully complete and the spermatozoa nuclei remain fragile and sensitive to external assaults.</p><p>In summary, the functional analysis of ATAD2 during its physiological expression in the post-meiotic phases of spermatogenesis supports our previous conclusions regarding its role in ES cells and its conserved activity in <italic>S. pombe</italic>. Together, these studies reveal a novel layer of regulation in histone turnover and chromatin dynamics, based on the control of histone-bound histone chaperone release.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Reagent type (species) or resource</th><th align="left" valign="top">Designation</th><th align="left" valign="top">Source or reference</th><th align="left" valign="top">Identifiers</th><th align="left" valign="top">Additional information</th></tr></thead><tbody><tr><td align="left" valign="top">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="top"><italic>Atad2</italic> knockout-first’ allele</td><td align="left" valign="top"><xref ref-type="bibr" rid="bib41">Skarnes et al., 2011</xref></td><td align="left" valign="top">KO mice</td><td align="left" valign="top">International KO Mouse Consortium; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:MGI:4432934">MGI:4432934</ext-link></td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="top"><italic>Atad2<sup>LacZΔNeo-Exon12</sup></italic></td><td align="left" valign="top">This paper</td><td align="left" valign="top">KO mice</td><td align="left" valign="top"><italic>Atad2</italic> ko-first’ allele mice were crossed with CMV-Cre mice; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:MGI:4432934">MGI:4432934</ext-link></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top"><italic>Atad2</italic>_84231_F</td><td align="left" valign="top">Eurogentec</td><td align="left" valign="top">Forward primer</td><td align="left" valign="top"><named-content content-type="sequence">TATCCAACAAGCCTGAGCCC</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top"><italic>Atad2</italic>_84231_R</td><td align="left" valign="top">Eurogentec</td><td align="left" valign="top">Reverse primer</td><td align="left" valign="top"><named-content content-type="sequence">CAACTGGAGCTGGGTCTTCC</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">Cas-R</td><td align="left" valign="top">Eurogentec</td><td align="left" valign="top">Reverse primer</td><td align="left" valign="top"><named-content content-type="sequence">TCGTGGTATCGTTATGCGCC</named-content></td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Bovine Serum Albumin</td><td align="left" valign="top">Euromedex</td><td align="left" valign="top">Cat# 04-100-812-C</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Clarity Western ECL Substrate</td><td align="left" valign="top">Bio-Rad</td><td align="left" valign="top">Cat # 170-5061</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">Clarity Max Western ECL Substrate</td><td align="left" valign="top">Bio-Rad</td><td align="left" valign="top">Cat # 170-5062</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Complete Protease inhibitor EDTA-free</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# 4693159001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Dako Fluorescent Mounting Medium</td><td align="left" valign="top">Dako</td><td align="left" valign="top">Cat# S3023</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">DL-Dithiothreitol</td><td align="left" valign="top">Euromedex</td><td align="left" valign="top">Cat# EU0006</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">DNase I recombinant</td><td align="left" valign="top">Roche</td><td align="left" valign="top">Cat# 4536282001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">DPBS</td><td align="left" valign="top">Gibco</td><td align="left" valign="top">Cat# 14200-075</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">EDTA</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# E6635</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">EGTA</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# E3889</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Formalin solution, neutral buffered, 10%</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# HT5012</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Glutaraldehyde solution</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# G5882</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Heparin sodium salt</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# H3149</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Hoechst</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">Cat# 33342</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Human Chorionic Gonadotropin</td><td align="left" valign="top">MED-VET</td><td align="left" valign="top">Cat# Chorulon</td><td align="left" valign="top">1500 UI</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Laemmli Sample Buffer</td><td align="left" valign="top">BioRad</td><td align="left" valign="top">Cat# 1610747</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Magnesium Chloride</td><td align="left" valign="top">Euromedex</td><td align="left" valign="top">Cat# 2189</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Mayer’s Hematoxylin Solution</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# MHS16</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">M2 medium</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# M7167</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">M16 medium</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# M7292</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Nitrocellulose Blotting membrane</td><td align="left" valign="top">Amersham Protran</td><td align="left" valign="top">Cat# 10600015</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Nonidet P 40 Substitute</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# 74385</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">NuPAGE 4–12% Bis-Tris Gel</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">Cat# NP0335BOX</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Potassium Ferricyanide</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# P-8131</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Potassium Ferrocyanide</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# P-9387</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Pregnant Mare Serum Gonadotropin (PMSG)</td><td align="left" valign="top">MED-VET</td><td align="left" valign="top">Cat# Syncro-part PMSG 600 UI</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Saccharose</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# S7903</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Saponin from quillaja bark</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# S7900</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Sodium deoxycholate</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# D6750</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">Superfrostslides</td><td align="left" valign="top">Thermo Scientific</td><td align="left" valign="top">Cat# LCSF05</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay or kit</td><td align="left" valign="top">TMB ELISA Substrate (High Sensitivity)</td><td align="left" valign="top">Abcam</td><td align="left" valign="top">Cat# AB171523</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Trans-Blot Turbo 5X Transfer Buffer</td><td align="left" valign="top">BioRad</td><td align="left" valign="top">Cat# 10026938</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Triton X-100</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# T9284</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">TRIzol</td><td align="left" valign="top">Thermo Scientific</td><td align="left" valign="top">Cat# 15596026</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">TWEEN 20</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# P7949</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Urea</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">Cat# U5378</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">X-Gal</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">Cat# B1690</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Other</td><td align="left" valign="top">96 Well Round (U) Bottom Plate</td><td align="left" valign="top">Thermo Scientific</td><td align="left" valign="top">Cat# 163320</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">450 nm Stop Solution for TMB Substrate</td><td align="left" valign="top">Abcam</td><td align="left" valign="top">Cat# AB171529</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-H2B testis specific (rabbit polyclonal)</td><td align="left" valign="top">Abcam</td><td align="left" valign="top"> Cat# ab178426</td><td align="left" valign="top">IF (1:100); RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_3720329">AB_3720329</ext-link></td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-ATAD2 (rabbit polyclonal)</td><td align="left" valign="top">Homemade</td><td align="left" valign="top">This paper</td><td align="left" valign="top">WB (1:1000)<break/>generated by Covalab, France</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-H2A.L1/L2 (rabbit polyclonal)</td><td align="left" valign="top">Homemade</td><td align="left" valign="top">SAB771</td><td align="left" valign="top">IHC (1:200)<break/>generated by Covalab, France</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Histone H3 (rabbit polyclonal)</td><td align="left" valign="top">Abcam</td><td align="left" valign="top">Cat#: Ab1791</td><td align="left" valign="top">WB (1:5000); RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_302613">AB_302613</ext-link></td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-H3F3B (mouse monoclonal)</td><td align="left" valign="top">Abnova</td><td align="left" valign="top">Cat#: H00003021-M01</td><td align="left" valign="top">IF (1:200); RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_425473">AB_425473</ext-link></td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-H4K5Ac (mouse monoclonal)</td><td align="left" valign="top">PTM Biolabs</td><td align="left" valign="top">Cat#: PTM-163</td><td align="left" valign="top">IHC (1:200); RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_3717383">AB_3717383</ext-link></td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Hira (D6O8L) (rabbit monoclonal)</td><td align="left" valign="top">Cell Signaling Technology</td><td align="left" valign="top">Cat#: 12463</td><td align="left" valign="top">WB (1:1000); RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2797927">AB_2797927</ext-link></td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-Pre-PRM2 (rabbit polyclonal)</td><td align="left" valign="top">Homemade</td><td align="left" valign="top">No reference</td><td align="left" valign="top">IF (1:100); generated by Covalab, France</td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-PRM1 (mouse monoclonal)</td><td align="left" valign="top">BRIAR Patch Biosciences</td><td align="left" valign="top">Cat#: HUP1N</td><td align="left" valign="top">IHC (1:200); RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2651186">AB_2651186</ext-link></td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-PRM2 (mouse monoclonal)</td><td align="left" valign="top">BRIAR Patch Biosciences</td><td align="left" valign="top">Cat#: HUP2B</td><td align="left" valign="top">IHC (1:200); RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2687949">AB_2687949</ext-link></td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Anti-TNP2 (B-2, mouse monoclonal)</td><td align="left" valign="top">Santa Cruz Biotechnology</td><td align="left" valign="top">Cat#: sc-393843</td><td align="left" valign="top">IHC (1:200); RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_3720327">AB_3720327</ext-link></td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Goat anti-rabbit IgG (H+L)-HRP</td><td align="left" valign="top">Bio-Rad</td><td align="left" valign="top">Cat# 170–6515</td><td align="left" valign="top">WB (1:5000);<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_11125142">AB_11125142</ext-link></td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Goat anti-mouse IgG (H+L)-HRP</td><td align="left" valign="top">Bio-Rad</td><td align="left" valign="top">Cat# 170–6516</td><td align="left" valign="top">WB (1:5000); RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_11125547">AB_11125547</ext-link></td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Alexa Fluor 568 Goat anti-mouse IgG (H+L)</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">Cat# A-11004</td><td align="left" valign="top">IF (1:500); RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2534072">AB_2534072</ext-link></td></tr><tr><td align="left" valign="top">Antibody</td><td align="left" valign="top">Alexa Fluor 488 Goat anti-rabbit IgG (H+L)</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top">Cat# A-11034</td><td align="left" valign="top">IF (1:500); RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:AB_2576217">AB_2576217</ext-link></td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animal care and breeding</title><p>Mice were housed at the Grenoble High Technology Animal Facility (PHTA). Mice were euthanized following a procedure approved by the official ethics committee of the University Grenoble Alpes (COMETH, C2EA-12). The investigators directly involved in care and breeding of mice had an official animal-handling authorization obtained after 2 weeks of intensive training and a final formal evaluation.</p></sec><sec id="s4-2"><title>Generation of <italic>Atad2</italic>-KO mice</title><p><italic>Atad2</italic> KO mice were obtained from the International Knockout Mouse Consortium, the Welcome Trust Sanger Institute, UK. The ‘knockout-first’ allele (tm1a) contains an IRES: <italic>lacZ</italic> trapping cassette and a floxed human β<italic>-actin</italic> promoter-driven <italic>neo</italic> cassette inserted into the intron 12 of the <italic>Atad2</italic> gene (<xref ref-type="bibr" rid="bib41">Skarnes et al., 2011</xref>). We created <italic>Atad2<sup>ΔNeo-Exon 12</sup></italic> mice by crossing mice bearing the <italic>tm1a</italic> allele with mice expressing Cre recombinase under the control of a ubiquitous human promoter CMV. This cross results in an <italic>Atad2<sup>LacZΔNeo-Exon12</sup></italic> knockout mouse with the first 11 exons of <italic>Atad2</italic> being fused to β-gal, leading to a non-functional ATAD2 protein depleted of its bromodomain and AAA+ATPase domain.</p><p>For <italic>Atad2</italic> KO mice genotyping, multiplex PCR was used to detect LacZ cassette producing a 393 bp WT band and a 293 bp mutant band using primers <italic>Atad2</italic>_84231_F, <named-content content-type="sequence">TATCCAACAAGCCTGAGCCC</named-content>, <italic>Atad2</italic>_84231_R, <named-content content-type="sequence">CAACTGGAGCTGGGTCTTCC</named-content> and Cas-R, <named-content content-type="sequence">TCGTGGTATCGTTATGCGCC</named-content>.</p></sec><sec id="s4-3"><title>Fertility test</title><p>Fertility tests were carried out with sexually mature 3-month-old males. Five WT males and five <italic>Atad2</italic> KO males were crossed with two C57BL6 females each, during 3 months, and the litter sizes were monitored during this period.</p></sec><sec id="s4-4"><title>In vitro fertilization</title><p>Eggs were obtained from 6- to 7-week-old superovulated C57/BL6J females, stimulated by a first injection of 7.5 UI of PMSG (Pregnant Mare Serum Gonadotropin), followed 48 hours later by a second injection of 7.5 UI of HCG (Human Chorionic Gonadotropin). Fourteen hours later, females were euthanized by cervical dislocation, and cumulus-oocyte complexes (COCs) released from the ampulla were collected in 500 µL M2 medium. Spermatozoa from wild type and <italic>Atad2</italic> KO males were harvested by dilaceration of the cauda epididymitis and allowed to swim in 1 mL M2 medium for 10 minutes at 37°C. Two hundred microliters of sperm were transferred into 800 µL M16/2% BSA and capacitated for 80 minutes at 37°C /5% CO<sub>₂</sub>. Finally, 300,000 sperm were simultaneously added to the COCs and incubated in M16 medium at 37°C/5% CO₂. After 4 hours of incubation, unbound spermatozoa were removed by three successive washes with 500 µL of M16. Twenty-four hours after fertilization, unfertilized eggs and two-cell embryos (as an indication of successful fertilization) were scored.</p></sec><sec id="s4-5"><title>Protein extraction and immunoblotting</title><p>Proteins were extracted in 8 M urea, sonicated at 150 J with a probe sonicator, mixed with 4x Laemli loading buffer and heated for 5 minutes at 95°C. Protein samples were loaded on 4–12% Bis-Tris gels and migrated at 150 V for 1 hour 30 minutes. The transfer step was realized using a nitrocellulose membrane with the Bio-Rad Transfer Turbo machine. Nitrocellulose membrane was blocked in 5% milk PBS-Tween 0.1% solution, washed 3 times for 10 minutes with PBS-Tween 0.1% solution, and incubated overnight at 4°C with specific antibodies listed in <bold>Key resources table</bold>. Membranes were washed three times for 10 minutes with PBS-Tween 0.1% solution and were incubated with HRP secondary antibodies at 1/10,000 dilution for 1 hour at RT under agitation. Revelation was performed using ECL substrates and visualization was performed with the Vilber Fusion FX Chemiluminescence imaging system (Vilber).</p></sec><sec id="s4-6"><title>ELISA</title><p>Urea protein extracts were diluted in PBS and used to coat 96-well round-bottom plates, followed by overnight incubation at 4°C. Coating solution was removed and wells were washed three times with washing buffer (BSA 1%, PBS-T 0.1%). Wells were blocked with blocking buffer (5% BSA in PBS-T 0.1%) for 2 hours at room temperature under agitation. The blocking buffer was removed and wells were washed 2 times with washing buffer. Primary antibodies for pre-PRM2 (1:1000) and tubulin (1:5000) were diluted into blocking buffer, pipetted into their corresponding wells, and incubated overnight at 4°C under mild agitation. Wells were washed four times with washing buffer, and subsequent incubation with secondary HRP antibodies, diluted 1:5000 in blocking buffer, was performed for 1 hour at room temperature under mild agitation. Wells were washed four times with washing buffer, and TMB ELISA Substrate was added to wells and incubated until the color developed, at which time Stop Solution was added to the wells to stop the reaction. The signal was quantified using a plate reader at 450 nm.</p></sec><sec id="s4-7"><title>X-Gal staining</title><p>Male mice were euthanized by cervical dislocation. Testes were dissected out, drilled in three points, and incubated overnight at 4℃ under agitation in fixative solution (0.5% glutaraldehyde, 2 mM MgCl<sub>2</sub> and 5 mM EGTA in PBS). After incubation until equilibration in an equilibration buffer (30% sucrose, 2 mM MgCl<sub>2</sub> and 5 mM EGTA in PBS), testes were frozen individually in OCT on dry ice. Frozen blocks were sectioned at 10 µm slices on Superfrost slides and let dry overnight. Slides were fixed with fixation buffer (0.2% glutaraldehyde, 100 mM MgCl<sub>2</sub> and 5 mM EGTA in PBS) for 10 minutes, washed with washing buffer (PBS, 0.02% NP-40, 0.01% sodium deoxycholate, and 2 mM MgCl<sub>2</sub>) for 5 minutes and incubated three times in 50% ethanol for 5 minutes each. Then the slides were stained with staining solution (2 mM MgCl<sub>2</sub>, 0.02% NP-40, 0.01% Na Doc, 5 mM potassium ferricyanide, 10 mM potassium ferrocyanide, and 0.5 mg/mL X-gal) in a wet chamber for several hours at 37℃. The slides were then washed with washing buffer for 5 minutes and with distilled water, and a counterstaining was performed with hematoxylin. Finally, the slides were washed with running tap water for several minutes and mounted with Dako fluorescent mounting medium.</p></sec><sec id="s4-8"><title>Immunofluorescence staining of germ cells</title><p>Staged seminiferous tubules were prepared as detailed in <xref ref-type="bibr" rid="bib17">Gaucher et al., 2012</xref>. In order to permeabilize the cells, the slides were placed in 0.5% saponin, 0.2% Triton X-100, and 1×PBS at RT for 15 minutes and washed for 5 minutes with PBS. The preparations were then incubated in 5% milk, 0.2% PBS-Tween blocking buffer, at RT for 30 minutes under agitation. The primary antibodies were diluted in 1% dry milk, 0.2% PBS-Tween buffer. The slides were incubated overnight with this diluted solution of the primary antibodies in a humidified chamber at 4℃ and then washed three times for 5 minutes each in the antibodies’ dilution buffer. The secondary antibodies were diluted at 1:500 in the same buffer and incubated in a humidified chamber for 30 minutes at 37℃, and then washed as for the primary antibodies. The DNA was counterstained with Hoechst, and the slides were mounted using Dako fluorescent mounting medium.</p></sec><sec id="s4-9"><title>Sperm head decompaction test</title><p>Spermatozoa from wild type and <italic>Atad2</italic> KO males were harvested by dilaceration of the cauda epididymis and allowed to swim in 1 mL M2 medium for 10 minutes at 37°C. The sperm-containing suspension was transferred into a 1.5 mL Eppendorf tube and centrifuged at 3000 rpm for 8 minutes in 4℃. The sperm pellets were resuspended in PBS and dropped onto glass slides to spread and dry at RT. The decompaction mix (50 mM DTT, 400 IU/mL heparin, and 0.2% Triton in PBS) was added to each dried sperm drop for 2 minutes and the decompaction was stopped by placing the slides in 4% PFA for 15 minutes. Slides were washed with PBS for 5 minutes, stained with DAPI, and mounted using Dako fluorescent mounting medium. Fluorescent images were captured by a Zeiss inverted microscope under a 63x numeric aperture oil-immersion lens (Carl Zeiss). The size of spermatozoa heads was calculated with ImageJ software.</p></sec><sec id="s4-10"><title>Spermatogenic cell fraction purification</title><p>Spermatogenic cell fraction purification was performed as previously described (<xref ref-type="bibr" rid="bib40">Shiota et al., 2018</xref>).</p></sec><sec id="s4-11"><title>ATAC-seq and data analysis</title><sec id="s4-11-1"><title>Library preparation</title><p>Frozen nuclei from four biologically independent purified spermatid fractions were centrifuged at 3000 <italic>× g</italic> for 5 minutes and then washed in a 1% BSA-PBS solution. Libraries were then prepared from 100,000 nuclei using the ATAC-seq Kit (Catalog No. 53150) from Active Motif, following the manufacturer’s protocol (version B9). After quality control (QC) with Qubit and Fragment Analyzer, libraries were subsequently purified using AMPure XP (Beckman Coulter, Catalog No. A63881) beads with a double size selection of 100–800 bp fragments. After a second round of library QC (Qubit and Fragment Analyzer), we performed a paired-end sequencing on a NextSeq 2000 device using a 200-cycle P2 flow cell.</p></sec><sec id="s4-11-2"><title>Trimming</title><p>The raw fastq files were processed by 5’ end trimming, keeping 30bp-length fragments, using fastx_trimmer (<ext-link ext-link-type="uri" xlink:href="http://hannonlab.cshl.edu/fastx_toolkit/">http://hannonlab.cshl.edu/fastx_toolkit/</ext-link>. accessed 28 February 2022), with options -l 30 -Q33.</p></sec><sec id="s4-11-3"><title>Alignment</title><p>The trimmed fastq files were aligned on the UCSC Mus_musculus mm10 genome using the Bowtie2 aligner (<xref ref-type="bibr" rid="bib25">Langmead and Salzberg, 2012</xref>), with options –end-to-end, –no-mixed, –no-discordant.</p></sec><sec id="s4-11-4"><title>Normalization</title><p>The BigWig files (.bw) containing normalized integrated aligned read count signals were obtained from by normalizing and smoothing bam files using bamCoverage (from deepTools suite <xref ref-type="bibr" rid="bib37">Ramírez et al., 2014</xref>) with options: –binSize 4 –minMappingQuality 30 –normalizeUsing RPM.</p></sec><sec id="s4-11-5"><title>Heatmap</title><p>The normalized ATAC-seq signal was converted into a 10 bp bin matrix of the signal 500b upstream and 1500b downstream protein-coding genes’ TSS, using computeMatrix (from deepTools suite <xref ref-type="bibr" rid="bib37">Ramírez et al., 2014</xref>), with options reference-point -R mm10_pc.bed –referencePoint TSS –binSize 10 –beforeRegionStartLength 500 –afterRegionStartLength 1500.</p><p>Heatmaps were generated using plotHeatmap (deepTools suite <xref ref-type="bibr" rid="bib37">Ramírez et al., 2014</xref>).</p></sec></sec><sec id="s4-12"><title>RNA-seq data processing</title><p>Wild-type (WT) and <italic>Atad2</italic> knockout (KO) homozygous males were sacrificed by cervical dislocation on days 20-, 22-, 24-, and 26- postpartum (PP), after which their testes were harvested. RNA was extracted using TRIzol reagent, followed by DNA digestion with DNase I. The resulting RNA samples were used for RNA sequencing. For both WT and <italic>Atad2</italic> KO mice, the biological replicates included three samples for D20, four samples for D22, two samples for D24, and two samples for D26.</p><p>The raw sequencing data (FASTQ files) were aligned to the UCSC mm10 mouse genome using the STAR software (version 2.7.11b) (<xref ref-type="bibr" rid="bib12">Dobin et al., 2013</xref>) to generate BAM files. Raw read counts were extracted from the BAM files using HTSeq (version 2.0.5) (<xref ref-type="bibr" rid="bib2">Anders et al., 2015</xref>) with the following parameters: -t exon, -f bam, -r pos, <monospace>--stranded=reverse</monospace>, -m intersection-strict, and <monospace>--nonunique</monospace> none.</p><p>Normalization of read counts was performed using the DESeq2 R package (version 1.22.2) (<xref ref-type="bibr" rid="bib1">Anders and Huber, 2010</xref>; <xref ref-type="bibr" rid="bib29">Love et al., 2014</xref>). Counts were transformed into DESeq2-normalized values and subsequently log-transformed using the formula log2(1+DESeq2-normalized counts). Differential expression analysis was conducted with the R package ‘SARTools‘ (<xref ref-type="bibr" rid="bib47">Varet et al., 2016</xref>).</p><p>Purified RNA from fractionated round spermatids was also sequenced to establish gene transcriptional group quartile shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>. RNA purification and sequencing were performed as described above.</p></sec><sec id="s4-13"><title>Quantification and statistical analysis</title><p>Statistical analysis was performed with R and GraphPad Prism 8. The results of fertility tests were analyzed by Student <italic>t</italic>-test. Pairwise Student <italic>t-</italic>test was used to analyze testis weights and spermatozoa counts of same-aged mice, and ratio pairwise Student <italic>t</italic>-test was used for the IVF efficiency results. The results of sperm decompaction test were analyzed by two-way ANOVA, and Tukey’s HSD post two-way ANOVA test was used to determine the significance between groups. <italic>P</italic>-values &lt;0.05 were considered statistically significant: *<italic>P</italic>&lt;0.05, **<italic>P</italic>&lt;0.01, ***<italic>P</italic>&lt;0.001.</p></sec><sec id="s4-14"><title>Gene Set Enrichment Analysis (GSEA)</title><p>Differential expression analysis and the corresponding GSEA analysis (<xref ref-type="bibr" rid="bib31">Mootha et al., 2003</xref>; <xref ref-type="bibr" rid="bib42">Subramanian et al., 2005</xref>) were performed to compare <italic>Atad2</italic> KO versus <italic>Atad2</italic> wild-type samples at days 20, 22, 24, and 26 PP. For the GSEA analysis, we used the Python package ‘gseapy‘ (<xref ref-type="bibr" rid="bib14">Fang et al., 2023</xref>) available at <ext-link ext-link-type="uri" xlink:href="https://www.gsea-msigdb.org/gsea">https://www.gsea-msigdb.org/gsea</ext-link>.</p><p>The GSEA was carried out on three custom gene sets. The first gene set, referred to as ‘sex chromosome-linked genes’, corresponds to genes located on the X and Y chromosomes. The remaining two gene sets include genes identified as upregulated or downregulated in the absence of histone H3.3 by Fontaine and colleagues (<xref ref-type="bibr" rid="bib15">Fontaine et al., 2022</xref>). These gene sets were designated as ‘post-meiotic H3.3-activated genes’ and ‘post-meiotic H3.3-repressed genes’, respectively.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Supervision, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Experimentation and data generation and analyses</p></fn><fn fn-type="con" id="con4"><p>Methodology</p></fn><fn fn-type="con" id="con5"><p>In vitro fertilization assays</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con7"><p>Transcriptomic data analyses</p></fn><fn fn-type="con" id="con8"><p>Transcriptomic data analyses</p></fn><fn fn-type="con" id="con9"><p>Transcriptomic data generation</p></fn><fn fn-type="con" id="con10"><p>Transcriptomic data generation</p></fn><fn fn-type="con" id="con11"><p>Funding acquisition, Transcriptomic data analyses</p></fn><fn fn-type="con" id="con12"><p>In vitro fertilization assays</p></fn><fn fn-type="con" id="con13"><p>Experimentation and data generation and analyses</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="fig" rid="fig7">Figure 7B</xref>, <xref ref-type="fig" rid="fig8">Figure 8</xref> and <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>.</title></caption><media xlink:href="elife-107582-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-107582-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>(1) The transcriptomic data generated in this study, corresponding to testes collected at different days post-partum, have been deposited on GEO under the accession GSE277943. (2) Transcriptomic data from fractionated round spermatids (three biological replicates, Fig. 4A) were deposited on GEO accession GSE284749. (3) ATAC-seq data generated in this study were deposited on GEO under the accession GSE283879.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Liakopoulou</surname><given-names>A</given-names></name><name><surname>Boussouar</surname><given-names>F</given-names></name><name><surname>Perazza</surname><given-names>D</given-names></name><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Lambert</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Chuffart</surname><given-names>F</given-names></name><name><surname>Bourova-Flin</surname><given-names>E</given-names></name><name><surname>Gard</surname><given-names>C</given-names></name><name><surname>Puthier</surname><given-names>D</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Arnoult</surname><given-names>C</given-names></name><name><surname>Verdel</surname><given-names>A</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>ATAD2 mediates chromatin-bound histone chaperone turnover</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277943">GSE277943</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Liakopoulou</surname><given-names>A</given-names></name><name><surname>Boussouar</surname><given-names>F</given-names></name><name><surname>Perazza</surname><given-names>D</given-names></name><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Lambert</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Chuffart</surname><given-names>F</given-names></name><name><surname>Bourova-Flin</surname><given-names>E</given-names></name><name><surname>Gard</surname><given-names>C</given-names></name><name><surname>Puthier</surname><given-names>D</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Arnoult</surname><given-names>C</given-names></name><name><surname>Verdel</surname><given-names>A</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>ATAD2 mediates chromatin-bound histone chaperone turnover</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284749">GSE284749</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset3"><person-group person-group-type="author"><name><surname>Liakopoulou</surname><given-names>A</given-names></name><name><surname>Boussouar</surname><given-names>F</given-names></name><name><surname>Perazza</surname><given-names>D</given-names></name><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Lambert</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Chuffart</surname><given-names>F</given-names></name><name><surname>Bourova-Flin</surname><given-names>E</given-names></name><name><surname>Gard</surname><given-names>C</given-names></name><name><surname>Puthier</surname><given-names>D</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Arnoult</surname><given-names>C</given-names></name><name><surname>Verdel</surname><given-names>A</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>ATAD2 mediates chromatin-bound histone chaperone turnover</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283879">GSE283879</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Fontaine</surname><given-names>E</given-names></name><name><surname>Papin</surname><given-names>C</given-names></name><name><surname>Martinez</surname><given-names>G</given-names></name><name><surname>Le Gras</surname><given-names>S</given-names></name><name><surname>Abi Nahed</surname><given-names>R</given-names></name><name><surname>Héry</surname><given-names>P</given-names></name><name><surname>Buchou</surname><given-names>T</given-names></name><name><surname>Ouararhni</surname><given-names>K</given-names></name><name><surname>Favier</surname><given-names>B</given-names></name><name><surname>Gautier</surname><given-names>T</given-names></name><name><surname>Sabir</surname><given-names>JSM</given-names></name><name><surname>Gérard</surname><given-names>M</given-names></name><name><surname>Bednar</surname><given-names>J</given-names></name><name><surname>Arnoult</surname><given-names>C</given-names></name><name><surname>Dimitrov</surname><given-names>S</given-names></name><name><surname>Hamiche</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Dual role of histone variant H3.3B in spermatogenesis: positive regulation of piRNA transcription and implication in X-chromosome inactivation</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116373">GSE116373</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by ANR EpiSperm 4 (ANR-19-CE12- 0014), ANR Episperm 5 (ANR-23-CE12-0028), ANR NME-CoA (ANR-23-CE14-0050) and the Cancer ITMO [Multi‐Organization Thematic Institute of the French Alliance for Life Sciences and Health (AVIESAN)] MIC program to SK and SR. AL is a recipient of a 4<sup>th</sup>-year PhD fellowship by Foundation pour la Recherche Médicale (FRM). High-throughput sequencing was performed at the TGML Platform, supported by grants from Inserm, GIS IBiSA, Aix-Marseille Université. We thank Dr. Alexandra Varga for X-gal staining of testis sections. The authors thank Dr Kelly Matmati, Stroke Program Director, Rochester General Hospital, Connecticut, USA, for her critical reading of the manuscript.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname><given-names>S</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Differential expression analysis for sequence count data</article-title><source>Genome Biology</source><volume>11</volume><elocation-id>R106</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2010-11-10-r106</pub-id><pub-id pub-id-type="pmid">20979621</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname><given-names>S</given-names></name><name><surname>Pyl</surname><given-names>PT</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HTSeq--a Python framework to work with high-throughput sequencing data</article-title><source>Bioinformatics</source><volume>31</volume><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu638</pub-id><pub-id pub-id-type="pmid">25260700</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arévalo</surname><given-names>L</given-names></name><name><surname>Esther Merges</surname><given-names>G</given-names></name><name><surname>Schneider</surname><given-names>S</given-names></name><name><surname>Schorle</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Protamines: lessons learned from mouse models</article-title><source>Reproduction</source><volume>164</volume><fpage>R57</fpage><lpage>R74</lpage><pub-id pub-id-type="doi">10.1530/REP-22-0107</pub-id><pub-id pub-id-type="pmid">35900356</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>J</given-names></name><name><surname>Bedford</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Epigenetic regulation of the histone-to-protamine transition during spermiogenesis</article-title><source>Reproduction</source><volume>151</volume><fpage>R55</fpage><lpage>R70</lpage><pub-id pub-id-type="doi">10.1530/REP-15-0562</pub-id><pub-id pub-id-type="pmid">26850883</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Morozumi</surname><given-names>Y</given-names></name><name><surname>Hoghoughi</surname><given-names>N</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>The mystery of histone disappearance during spermatogenesis</article-title><source>Medecine Sciences</source><volume>33</volume><fpage>588</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1051/medsci/20173306010</pub-id><pub-id pub-id-type="pmid">28990555</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Morozumi</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Montellier</surname><given-names>E</given-names></name><name><surname>Govin</surname><given-names>J</given-names></name><name><surname>de Dieuleveult</surname><given-names>M</given-names></name><name><surname>Charbonnier</surname><given-names>G</given-names></name><name><surname>Couté</surname><given-names>Y</given-names></name><name><surname>Puthier</surname><given-names>D</given-names></name><name><surname>Buchou</surname><given-names>T</given-names></name><name><surname>Boussouar</surname><given-names>F</given-names></name><name><surname>Urahama</surname><given-names>T</given-names></name><name><surname>Fenaille</surname><given-names>F</given-names></name><name><surname>Curtet</surname><given-names>S</given-names></name><name><surname>Héry</surname><given-names>P</given-names></name><name><surname>Fernandez-Nunez</surname><given-names>N</given-names></name><name><surname>Shiota</surname><given-names>H</given-names></name><name><surname>Gérard</surname><given-names>M</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Kurumizaka</surname><given-names>H</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Histone variant H2A.L.2 guides transition protein-dependent protamine assembly in male germ cells</article-title><source>Molecular Cell</source><volume>66</volume><fpage>89</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.02.025</pub-id><pub-id pub-id-type="pmid">28366643</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bashiri</surname><given-names>Z</given-names></name><name><surname>Amidi</surname><given-names>F</given-names></name><name><surname>Amiri</surname><given-names>I</given-names></name><name><surname>Zandieh</surname><given-names>Z</given-names></name><name><surname>Maki</surname><given-names>CB</given-names></name><name><surname>Mohammadi</surname><given-names>F</given-names></name><name><surname>Amiri</surname><given-names>S</given-names></name><name><surname>Koruji</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Male factors: the role of sperm in preimplantation embryo quality</article-title><source>Reproductive Sciences</source><volume>28</volume><fpage>1788</fpage><lpage>1811</lpage><pub-id pub-id-type="doi">10.1007/s43032-020-00334-z</pub-id><pub-id pub-id-type="pmid">33140326</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boussouar</surname><given-names>F</given-names></name><name><surname>Jamshidikia</surname><given-names>M</given-names></name><name><surname>Morozumi</surname><given-names>Y</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Malignant genome reprogramming by ATAD2</article-title><source>Biochimica et Biophysica Acta</source><volume>1829</volume><fpage>1010</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1016/j.bbagrm.2013.06.003</pub-id><pub-id pub-id-type="pmid">23831842</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caron</surname><given-names>C</given-names></name><name><surname>Lestrat</surname><given-names>C</given-names></name><name><surname>Marsal</surname><given-names>S</given-names></name><name><surname>Escoffier</surname><given-names>E</given-names></name><name><surname>Curtet</surname><given-names>S</given-names></name><name><surname>Virolle</surname><given-names>V</given-names></name><name><surname>Barbry</surname><given-names>P</given-names></name><name><surname>Debernardi</surname><given-names>A</given-names></name><name><surname>Brambilla</surname><given-names>C</given-names></name><name><surname>Brambilla</surname><given-names>E</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers</article-title><source>Oncogene</source><volume>29</volume><fpage>5171</fpage><lpage>5181</lpage><pub-id pub-id-type="doi">10.1038/onc.2010.259</pub-id><pub-id pub-id-type="pmid">20581866</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattaneo</surname><given-names>M</given-names></name><name><surname>Morozumi</surname><given-names>Y</given-names></name><name><surname>Perazza</surname><given-names>D</given-names></name><name><surname>Boussouar</surname><given-names>F</given-names></name><name><surname>Jamshidikia</surname><given-names>M</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Verdel</surname><given-names>A</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Lessons from yeast on emerging roles of the ATAD2 protein family in gene regulation and genome organization</article-title><source>Molecules and Cells</source><volume>37</volume><fpage>851</fpage><lpage>856</lpage><pub-id pub-id-type="doi">10.14348/molcells.2014.0258</pub-id><pub-id pub-id-type="pmid">25377252</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Dieuleveult</surname><given-names>M</given-names></name><name><surname>Yen</surname><given-names>K</given-names></name><name><surname>Hmitou</surname><given-names>I</given-names></name><name><surname>Depaux</surname><given-names>A</given-names></name><name><surname>Boussouar</surname><given-names>F</given-names></name><name><surname>Bou Dargham</surname><given-names>D</given-names></name><name><surname>Jounier</surname><given-names>S</given-names></name><name><surname>Humbertclaude</surname><given-names>H</given-names></name><name><surname>Ribierre</surname><given-names>F</given-names></name><name><surname>Baulard</surname><given-names>C</given-names></name><name><surname>Farrell</surname><given-names>NP</given-names></name><name><surname>Park</surname><given-names>B</given-names></name><name><surname>Keime</surname><given-names>C</given-names></name><name><surname>Carrière</surname><given-names>L</given-names></name><name><surname>Berlivet</surname><given-names>S</given-names></name><name><surname>Gut</surname><given-names>M</given-names></name><name><surname>Gut</surname><given-names>I</given-names></name><name><surname>Werner</surname><given-names>M</given-names></name><name><surname>Deleuze</surname><given-names>J-F</given-names></name><name><surname>Olaso</surname><given-names>R</given-names></name><name><surname>Aude</surname><given-names>J-C</given-names></name><name><surname>Chantalat</surname><given-names>S</given-names></name><name><surname>Pugh</surname><given-names>BF</given-names></name><name><surname>Gérard</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genome-wide nucleosome specificity and function of chromatin remodellers in ES cells</article-title><source>Nature</source><volume>530</volume><fpage>113</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1038/nature16505</pub-id><pub-id pub-id-type="pmid">26814966</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyer</surname><given-names>SC</given-names></name><name><surname>Austine-Orimoloye</surname><given-names>O</given-names></name><name><surname>Azov</surname><given-names>AG</given-names></name><name><surname>Barba</surname><given-names>M</given-names></name><name><surname>Barnes</surname><given-names>I</given-names></name><name><surname>Barrera-Enriquez</surname><given-names>VP</given-names></name><name><surname>Becker</surname><given-names>A</given-names></name><name><surname>Bennett</surname><given-names>R</given-names></name><name><surname>Beracochea</surname><given-names>M</given-names></name><name><surname>Berry</surname><given-names>A</given-names></name><name><surname>Bhai</surname><given-names>J</given-names></name><name><surname>Bhurji</surname><given-names>SK</given-names></name><name><surname>Boddu</surname><given-names>S</given-names></name><name><surname>Branco Lins</surname><given-names>PR</given-names></name><name><surname>Brooks</surname><given-names>L</given-names></name><name><surname>Ramaraju</surname><given-names>SB</given-names></name><name><surname>Campbell</surname><given-names>LI</given-names></name><name><surname>Martinez</surname><given-names>MC</given-names></name><name><surname>Charkhchi</surname><given-names>M</given-names></name><name><surname>Cortes</surname><given-names>LA</given-names></name><name><surname>Davidson</surname><given-names>C</given-names></name><name><surname>Denni</surname><given-names>S</given-names></name><name><surname>Dodiya</surname><given-names>K</given-names></name><name><surname>Donaldson</surname><given-names>S</given-names></name><name><surname>El Houdaigui</surname><given-names>B</given-names></name><name><surname>El Naboulsi</surname><given-names>T</given-names></name><name><surname>Falola</surname><given-names>O</given-names></name><name><surname>Fatima</surname><given-names>R</given-names></name><name><surname>Genez</surname><given-names>T</given-names></name><name><surname>Martinez</surname><given-names>JG</given-names></name><name><surname>Gurbich</surname><given-names>T</given-names></name><name><surname>Hardy</surname><given-names>M</given-names></name><name><surname>Hollis</surname><given-names>Z</given-names></name><name><surname>Hunt</surname><given-names>T</given-names></name><name><surname>Kay</surname><given-names>M</given-names></name><name><surname>Kaykala</surname><given-names>V</given-names></name><name><surname>Lemos</surname><given-names>D</given-names></name><name><surname>Lodha</surname><given-names>D</given-names></name><name><surname>Mathlouthi</surname><given-names>N</given-names></name><name><surname>Merino</surname><given-names>GA</given-names></name><name><surname>Merritt</surname><given-names>R</given-names></name><name><surname>Mirabueno</surname><given-names>LP</given-names></name><name><surname>Mushtaq</surname><given-names>A</given-names></name><name><surname>Hossain</surname><given-names>SN</given-names></name><name><surname>Pérez-Silva</surname><given-names>JG</given-names></name><name><surname>Perry</surname><given-names>M</given-names></name><name><surname>Piližota</surname><given-names>I</given-names></name><name><surname>Poppleton</surname><given-names>D</given-names></name><name><surname>Prosovetskaia</surname><given-names>I</given-names></name><name><surname>Raj</surname><given-names>S</given-names></name><name><surname>Salam</surname><given-names>AIA</given-names></name><name><surname>Saraf</surname><given-names>S</given-names></name><name><surname>Saraiva-Agostinho</surname><given-names>N</given-names></name><name><surname>Sinha</surname><given-names>S</given-names></name><name><surname>Sipos</surname><given-names>B</given-names></name><name><surname>Sitnik</surname><given-names>V</given-names></name><name><surname>Steed</surname><given-names>E</given-names></name><name><surname>Suner</surname><given-names>M-M</given-names></name><name><surname>Surapaneni</surname><given-names>L</given-names></name><name><surname>Sutinen</surname><given-names>K</given-names></name><name><surname>Tricomi</surname><given-names>FF</given-names></name><name><surname>Tsang</surname><given-names>I</given-names></name><name><surname>Urbina-Gómez</surname><given-names>D</given-names></name><name><surname>Veidenberg</surname><given-names>A</given-names></name><name><surname>Walsh</surname><given-names>TA</given-names></name><name><surname>Willhoft</surname><given-names>NL</given-names></name><name><surname>Allen</surname><given-names>J</given-names></name><name><surname>Alvarez-Jarreta</surname><given-names>J</given-names></name><name><surname>Chakiachvili</surname><given-names>M</given-names></name><name><surname>Cheema</surname><given-names>J</given-names></name><name><surname>da Rocha</surname><given-names>JB</given-names></name><name><surname>De Silva</surname><given-names>NH</given-names></name><name><surname>Giorgetti</surname><given-names>S</given-names></name><name><surname>Haggerty</surname><given-names>L</given-names></name><name><surname>Ilsley</surname><given-names>GR</given-names></name><name><surname>Keatley</surname><given-names>J</given-names></name><name><surname>Loveland</surname><given-names>JE</given-names></name><name><surname>Moore</surname><given-names>B</given-names></name><name><surname>Mudge</surname><given-names>JM</given-names></name><name><surname>Naamati</surname><given-names>G</given-names></name><name><surname>Tate</surname><given-names>J</given-names></name><name><surname>Trevanion</surname><given-names>SJ</given-names></name><name><surname>Winterbottom</surname><given-names>A</given-names></name><name><surname>Flint</surname><given-names>B</given-names></name><name><surname>Frankish</surname><given-names>A</given-names></name><name><surname>Hunt</surname><given-names>SE</given-names></name><name><surname>Finn</surname><given-names>RD</given-names></name><name><surname>Freeberg</surname><given-names>MA</given-names></name><name><surname>Harrison</surname><given-names>PW</given-names></name><name><surname>Martin</surname><given-names>FJ</given-names></name><name><surname>Yates</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Ensembl 2025</article-title><source>Nucleic Acids Research</source><volume>53</volume><fpage>D948</fpage><lpage>D957</lpage><pub-id pub-id-type="doi">10.1093/nar/gkae1071</pub-id><pub-id pub-id-type="pmid">39656687</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Peltz</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>GSEApy: a comprehensive package for performing gene set enrichment analysis in Python</article-title><source>Bioinformatics</source><volume>39</volume><elocation-id>btac757</elocation-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btac757</pub-id><pub-id pub-id-type="pmid">36426870</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontaine</surname><given-names>E</given-names></name><name><surname>Papin</surname><given-names>C</given-names></name><name><surname>Martinez</surname><given-names>G</given-names></name><name><surname>Le Gras</surname><given-names>S</given-names></name><name><surname>Nahed</surname><given-names>RA</given-names></name><name><surname>Héry</surname><given-names>P</given-names></name><name><surname>Buchou</surname><given-names>T</given-names></name><name><surname>Ouararhni</surname><given-names>K</given-names></name><name><surname>Favier</surname><given-names>B</given-names></name><name><surname>Gautier</surname><given-names>T</given-names></name><name><surname>Sabir</surname><given-names>JSM</given-names></name><name><surname>Gerard</surname><given-names>M</given-names></name><name><surname>Bednar</surname><given-names>J</given-names></name><name><surname>Arnoult</surname><given-names>C</given-names></name><name><surname>Dimitrov</surname><given-names>S</given-names></name><name><surname>Hamiche</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Dual role of histone variant H3.3B in spermatogenesis: positive regulation of piRNA transcription and implication in X-chromosome inactivation</article-title><source>Nucleic Acids Research</source><volume>50</volume><fpage>7350</fpage><lpage>7366</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac541</pub-id><pub-id pub-id-type="pmid">35766398</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaucher</surname><given-names>J</given-names></name><name><surname>Reynoird</surname><given-names>N</given-names></name><name><surname>Montellier</surname><given-names>E</given-names></name><name><surname>Boussouar</surname><given-names>F</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>From meiosis to postmeiotic events: the secrets of histone disappearance</article-title><source>The FEBS Journal</source><volume>277</volume><fpage>599</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.07504.x</pub-id><pub-id pub-id-type="pmid">20015078</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaucher</surname><given-names>J-F</given-names></name><name><surname>Maugé</surname><given-names>C</given-names></name><name><surname>Didry</surname><given-names>D</given-names></name><name><surname>Guichard</surname><given-names>B</given-names></name><name><surname>Renault</surname><given-names>L</given-names></name><name><surname>Carlier</surname><given-names>M-F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Interactions of isolated C-terminal fragments of neural Wiskott-Aldrich syndrome protein (N-WASP) with actin and Arp2/3 complex</article-title><source>The Journal of Biological Chemistry</source><volume>287</volume><fpage>34646</fpage><lpage>34659</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.394361</pub-id><pub-id pub-id-type="pmid">22847007</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goudarzi</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Kwon</surname><given-names>OK</given-names></name><name><surname>Qi</surname><given-names>S</given-names></name><name><surname>Tang</surname><given-names>Z</given-names></name><name><surname>Buchou</surname><given-names>T</given-names></name><name><surname>Vitte</surname><given-names>A-L</given-names></name><name><surname>He</surname><given-names>T</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Montellier</surname><given-names>E</given-names></name><name><surname>Gaucher</surname><given-names>J</given-names></name><name><surname>Curtet</surname><given-names>S</given-names></name><name><surname>Debernardi</surname><given-names>A</given-names></name><name><surname>Charbonnier</surname><given-names>G</given-names></name><name><surname>Puthier</surname><given-names>D</given-names></name><name><surname>Petosa</surname><given-names>C</given-names></name><name><surname>Panne</surname><given-names>D</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Roeder</surname><given-names>RG</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dynamic competing histone H4 K5K8 acetylation and butyrylation are hallmarks of highly active gene promoters</article-title><source>Molecular Cell</source><volume>62</volume><fpage>169</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.03.014</pub-id><pub-id pub-id-type="pmid">27105113</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname><given-names>CM</given-names></name><name><surname>Bao</surname><given-names>H</given-names></name><name><surname>Hendriks</surname><given-names>IA</given-names></name><name><surname>Carraro</surname><given-names>M</given-names></name><name><surname>García-Nieto</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Reverón-Gómez</surname><given-names>N</given-names></name><name><surname>Spanos</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Rappsilber</surname><given-names>J</given-names></name><name><surname>Nielsen</surname><given-names>ML</given-names></name><name><surname>Patel</surname><given-names>DJ</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Groth</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>DNAJC9 integrates heat shock molecular chaperones into the histone chaperone network</article-title><source>Molecular Cell</source><volume>81</volume><fpage>2533</fpage><lpage>2548</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2021.03.041</pub-id><pub-id pub-id-type="pmid">33857403</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoghoughi</surname><given-names>N</given-names></name><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Vargas</surname><given-names>A</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Histone variants: essential actors in male genome programming</article-title><source>Journal of Biochemistry</source><volume>163</volume><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1093/jb/mvx079</pub-id><pub-id pub-id-type="pmid">29165574</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>J</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Zofall</surname><given-names>M</given-names></name><name><surname>Cho</surname><given-names>C</given-names></name><name><surname>Grewal</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Song</surname><given-names>J-J</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Abo1 ATPase facilitates the dissociation of FACT from chromatin</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2024.06.17.599424</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krastev</surname><given-names>DB</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Wicks</surname><given-names>AJ</given-names></name><name><surname>Hoslett</surname><given-names>G</given-names></name><name><surname>Weekes</surname><given-names>D</given-names></name><name><surname>Badder</surname><given-names>LM</given-names></name><name><surname>Knight</surname><given-names>EG</given-names></name><name><surname>Marlow</surname><given-names>R</given-names></name><name><surname>Pardo</surname><given-names>MC</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Talele</surname><given-names>TT</given-names></name><name><surname>Bartek</surname><given-names>J</given-names></name><name><surname>Choudhary</surname><given-names>JS</given-names></name><name><surname>Pommier</surname><given-names>Y</given-names></name><name><surname>Pettitt</surname><given-names>SJ</given-names></name><name><surname>Tutt</surname><given-names>ANJ</given-names></name><name><surname>Ramadan</surname><given-names>K</given-names></name><name><surname>Lord</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin</article-title><source>Nature Cell Biology</source><volume>24</volume><fpage>62</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1038/s41556-021-00807-6</pub-id><pub-id pub-id-type="pmid">35013556</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krimer</surname><given-names>DB</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name><name><surname>Skoultchi</surname><given-names>AI</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Induction of H3.3 replacement histone mRNAs during the precommitment period of murine erythroleukemia cell differentiation</article-title><source>Nucleic Acids Research</source><volume>21</volume><fpage>2873</fpage><lpage>2879</lpage><pub-id pub-id-type="doi">10.1093/nar/21.12.2873</pub-id><pub-id pub-id-type="pmid">8332496</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafon</surname><given-names>A</given-names></name><name><surname>Taranum</surname><given-names>S</given-names></name><name><surname>Pietrocola</surname><given-names>F</given-names></name><name><surname>Dingli</surname><given-names>F</given-names></name><name><surname>Loew</surname><given-names>D</given-names></name><name><surname>Brahma</surname><given-names>S</given-names></name><name><surname>Bartholomew</surname><given-names>B</given-names></name><name><surname>Papamichos-Chronakis</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>INO80 chromatin remodeler facilitates release of RNA polymerase II from chromatin for ubiquitin-mediated proteasomal degradation</article-title><source>Molecular Cell</source><volume>60</volume><fpage>784</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.10.028</pub-id><pub-id pub-id-type="pmid">26656161</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast gapped-read alignment with Bowtie 2</article-title><source>Nature Methods</source><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Blévec</surname><given-names>E</given-names></name><name><surname>Muroňová</surname><given-names>J</given-names></name><name><surname>Ray</surname><given-names>PF</given-names></name><name><surname>Arnoult</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Paternal epigenetics: Mammalian sperm provide much more than DNA at fertilization</article-title><source>Molecular and Cellular Endocrinology</source><volume>518</volume><elocation-id>110964</elocation-id><pub-id pub-id-type="doi">10.1016/j.mce.2020.110964</pub-id><pub-id pub-id-type="pmid">32738444</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>CJ</given-names></name><name><surname>Koh</surname><given-names>FM</given-names></name><name><surname>Wong</surname><given-names>P</given-names></name><name><surname>Conti</surname><given-names>M</given-names></name><name><surname>Ramalho-Santos</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Hira-mediated H3.3 incorporation is required for DNA replication and ribosomal RNA transcription in the mouse zygote</article-title><source>Developmental Cell</source><volume>30</volume><fpage>268</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.06.022</pub-id><pub-id pub-id-type="pmid">25087892</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Wen</surname><given-names>Q</given-names></name><name><surname>Yan</surname><given-names>S</given-names></name><name><surname>Zeng</surname><given-names>W</given-names></name><name><surname>Zou</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Zou</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Tumor-promoting ATAD2 and its preclinical challenges</article-title><source>Biomolecules</source><volume>12</volume><elocation-id>1040</elocation-id><pub-id pub-id-type="doi">10.3390/biom12081040</pub-id><pub-id pub-id-type="pmid">36008934</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montellier</surname><given-names>E</given-names></name><name><surname>Boussouar</surname><given-names>F</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Buchou</surname><given-names>T</given-names></name><name><surname>Fenaille</surname><given-names>F</given-names></name><name><surname>Shiota</surname><given-names>H</given-names></name><name><surname>Debernardi</surname><given-names>A</given-names></name><name><surname>Héry</surname><given-names>P</given-names></name><name><surname>Curtet</surname><given-names>S</given-names></name><name><surname>Jamshidikia</surname><given-names>M</given-names></name><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Holota</surname><given-names>H</given-names></name><name><surname>Bergon</surname><given-names>A</given-names></name><name><surname>Lopez</surname><given-names>F</given-names></name><name><surname>Guardiola</surname><given-names>P</given-names></name><name><surname>Pernet</surname><given-names>K</given-names></name><name><surname>Imbert</surname><given-names>J</given-names></name><name><surname>Petosa</surname><given-names>C</given-names></name><name><surname>Tan</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Gérard</surname><given-names>M</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Chromatin-to-nucleoprotamine transition is controlled by the histone H2B variant TH2B</article-title><source>Genes &amp; Development</source><volume>27</volume><fpage>1680</fpage><lpage>1692</lpage><pub-id pub-id-type="doi">10.1101/gad.220095.113</pub-id><pub-id pub-id-type="pmid">23884607</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Eriksson</surname><given-names>K-F</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Sihag</surname><given-names>S</given-names></name><name><surname>Lehar</surname><given-names>J</given-names></name><name><surname>Puigserver</surname><given-names>P</given-names></name><name><surname>Carlsson</surname><given-names>E</given-names></name><name><surname>Ridderstråle</surname><given-names>M</given-names></name><name><surname>Laurila</surname><given-names>E</given-names></name><name><surname>Houstis</surname><given-names>N</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Patterson</surname><given-names>N</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Spiegelman</surname><given-names>B</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Groop</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</article-title><source>Nature Genetics</source><volume>34</volume><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1038/ng1180</pub-id><pub-id pub-id-type="pmid">12808457</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morinière</surname><given-names>J</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Steuerwald</surname><given-names>U</given-names></name><name><surname>Soler-López</surname><given-names>M</given-names></name><name><surname>Curtet</surname><given-names>S</given-names></name><name><surname>Vitte</surname><given-names>A-L</given-names></name><name><surname>Govin</surname><given-names>J</given-names></name><name><surname>Gaucher</surname><given-names>J</given-names></name><name><surname>Sadoul</surname><given-names>K</given-names></name><name><surname>Hart</surname><given-names>DJ</given-names></name><name><surname>Krijgsveld</surname><given-names>J</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name><name><surname>Müller</surname><given-names>CW</given-names></name><name><surname>Petosa</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cooperative binding of two acetylation marks on a histone tail by a single bromodomain</article-title><source>Nature</source><volume>461</volume><fpage>664</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1038/nature08397</pub-id><pub-id pub-id-type="pmid">19794495</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morozumi</surname><given-names>Y</given-names></name><name><surname>Boussouar</surname><given-names>F</given-names></name><name><surname>Tan</surname><given-names>M</given-names></name><name><surname>Chaikuad</surname><given-names>A</given-names></name><name><surname>Jamshidikia</surname><given-names>M</given-names></name><name><surname>Colak</surname><given-names>G</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Nie</surname><given-names>L</given-names></name><name><surname>Petosa</surname><given-names>C</given-names></name><name><surname>de Dieuleveult</surname><given-names>M</given-names></name><name><surname>Curtet</surname><given-names>S</given-names></name><name><surname>Vitte</surname><given-names>A-L</given-names></name><name><surname>Rabatel</surname><given-names>C</given-names></name><name><surname>Debernardi</surname><given-names>A</given-names></name><name><surname>Cosset</surname><given-names>F-L</given-names></name><name><surname>Verhoeyen</surname><given-names>E</given-names></name><name><surname>Emadali</surname><given-names>A</given-names></name><name><surname>Schweifer</surname><given-names>N</given-names></name><name><surname>Gianni</surname><given-names>D</given-names></name><name><surname>Gut</surname><given-names>M</given-names></name><name><surname>Guardiola</surname><given-names>P</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Gérard</surname><given-names>M</given-names></name><name><surname>Knapp</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Atad2 is a generalist facilitator of chromatin dynamics in embryonic stem cells</article-title><source>Journal of Molecular Cell Biology</source><volume>8</volume><fpage>349</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1093/jmcb/mjv060</pub-id><pub-id pub-id-type="pmid">26459632</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nashun</surname><given-names>B</given-names></name><name><surname>Hill</surname><given-names>PWS</given-names></name><name><surname>Smallwood</surname><given-names>SA</given-names></name><name><surname>Dharmalingam</surname><given-names>G</given-names></name><name><surname>Amouroux</surname><given-names>R</given-names></name><name><surname>Clark</surname><given-names>SJ</given-names></name><name><surname>Sharma</surname><given-names>V</given-names></name><name><surname>Ndjetehe</surname><given-names>E</given-names></name><name><surname>Pelczar</surname><given-names>P</given-names></name><name><surname>Festenstein</surname><given-names>RJ</given-names></name><name><surname>Kelsey</surname><given-names>G</given-names></name><name><surname>Hajkova</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Continuous histone replacement by hira is essential for normal transcriptional regulation and de novo DNA methylation during mouse oogenesis</article-title><source>Molecular Cell</source><volume>60</volume><fpage>611</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.10.010</pub-id><pub-id pub-id-type="pmid">26549683</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Sperm chromatin condensation: epigenetic mechanisms to compact the genome and spatiotemporal regulation from inside and outside the nucleus</article-title><source>Genes &amp; Genetic Systems</source><volume>97</volume><fpage>41</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1266/ggs.21-00065</pub-id><pub-id pub-id-type="pmid">35491100</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puumalainen</surname><given-names>MR</given-names></name><name><surname>Lessel</surname><given-names>D</given-names></name><name><surname>Rüthemann</surname><given-names>P</given-names></name><name><surname>Kaczmarek</surname><given-names>N</given-names></name><name><surname>Bachmann</surname><given-names>K</given-names></name><name><surname>Ramadan</surname><given-names>K</given-names></name><name><surname>Naegeli</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Chromatin retention of DNA damage sensors DDB2 and XPC through loss of p97 segregase causes genotoxicity</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>3695</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms4695</pub-id><pub-id pub-id-type="pmid">24770583</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramírez</surname><given-names>F</given-names></name><name><surname>Dündar</surname><given-names>F</given-names></name><name><surname>Diehl</surname><given-names>S</given-names></name><name><surname>Grüning</surname><given-names>BA</given-names></name><name><surname>Manke</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>deepTools: a flexible platform for exploring deep-sequencing data</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>W187</fpage><lpage>W191</lpage><pub-id pub-id-type="doi">10.1093/nar/gku365</pub-id><pub-id pub-id-type="pmid">24799436</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezaei-Gazik</surname><given-names>M</given-names></name><name><surname>Vargas</surname><given-names>A</given-names></name><name><surname>Amiri-Yekta</surname><given-names>A</given-names></name><name><surname>Vitte</surname><given-names>A-L</given-names></name><name><surname>Akbari</surname><given-names>A</given-names></name><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Esmaeili</surname><given-names>V</given-names></name><name><surname>Chuffart</surname><given-names>F</given-names></name><name><surname>Sadighi-Gilani</surname><given-names>MA</given-names></name><name><surname>Couté</surname><given-names>Y</given-names></name><name><surname>Eftekhari-Yazdi</surname><given-names>P</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Totonchi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Direct visualization of pre-protamine 2 detects protamine assembly failures and predicts ICSI success</article-title><source>Molecular Human Reproduction</source><volume>28</volume><elocation-id>gaac004</elocation-id><pub-id pub-id-type="doi">10.1093/molehr/gaac004</pub-id><pub-id pub-id-type="pmid">35150275</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Reynoird</surname><given-names>N</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>NUT is a driver of p300-mediated histone hyperacetylation: From spermatogenesis to cancer</article-title><source>Cancers</source><volume>14</volume><elocation-id>2234</elocation-id><pub-id pub-id-type="doi">10.3390/cancers14092234</pub-id><pub-id pub-id-type="pmid">35565363</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiota</surname><given-names>H</given-names></name><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Buchou</surname><given-names>T</given-names></name><name><surname>Tan</surname><given-names>M</given-names></name><name><surname>Couté</surname><given-names>Y</given-names></name><name><surname>Charbonnier</surname><given-names>G</given-names></name><name><surname>Reynoird</surname><given-names>N</given-names></name><name><surname>Boussouar</surname><given-names>F</given-names></name><name><surname>Gérard</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Bargier</surname><given-names>L</given-names></name><name><surname>Puthier</surname><given-names>D</given-names></name><name><surname>Chuffart</surname><given-names>F</given-names></name><name><surname>Bourova-Flin</surname><given-names>E</given-names></name><name><surname>Picaud</surname><given-names>S</given-names></name><name><surname>Filippakopoulos</surname><given-names>P</given-names></name><name><surname>Goudarzi</surname><given-names>A</given-names></name><name><surname>Ibrahim</surname><given-names>Z</given-names></name><name><surname>Panne</surname><given-names>D</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nut directs p300-dependent, genome-wide H4 hyperacetylation in male germ cells</article-title><source>Cell Reports</source><volume>24</volume><fpage>3477</fpage><lpage>3487</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.08.069</pub-id><pub-id pub-id-type="pmid">30257209</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skarnes</surname><given-names>WC</given-names></name><name><surname>Rosen</surname><given-names>B</given-names></name><name><surname>West</surname><given-names>AP</given-names></name><name><surname>Koutsourakis</surname><given-names>M</given-names></name><name><surname>Bushell</surname><given-names>W</given-names></name><name><surname>Iyer</surname><given-names>V</given-names></name><name><surname>Mujica</surname><given-names>AO</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Harrow</surname><given-names>J</given-names></name><name><surname>Cox</surname><given-names>T</given-names></name><name><surname>Jackson</surname><given-names>D</given-names></name><name><surname>Severin</surname><given-names>J</given-names></name><name><surname>Biggs</surname><given-names>P</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Nefedov</surname><given-names>M</given-names></name><name><surname>de Jong</surname><given-names>PJ</given-names></name><name><surname>Stewart</surname><given-names>AF</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A conditional knockout resource for the genome-wide study of mouse gene function</article-title><source>Nature</source><volume>474</volume><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/nature10163</pub-id><pub-id pub-id-type="pmid">21677750</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>MCW</given-names></name><name><surname>Jacobs</surname><given-names>SA</given-names></name><name><surname>Mattiske</surname><given-names>DM</given-names></name><name><surname>Soh</surname><given-names>YM</given-names></name><name><surname>Graham</surname><given-names>AN</given-names></name><name><surname>Tran</surname><given-names>A</given-names></name><name><surname>Lim</surname><given-names>SL</given-names></name><name><surname>Hudson</surname><given-names>DF</given-names></name><name><surname>Kalitsis</surname><given-names>P</given-names></name><name><surname>O’Bryan</surname><given-names>MK</given-names></name><name><surname>Wong</surname><given-names>LH</given-names></name><name><surname>Mann</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Contribution of the two genes encoding histone variant h3.3 to viability and fertility in mice</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1004964</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004964</pub-id><pub-id pub-id-type="pmid">25675407</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Berg</surname><given-names>SJW</given-names></name><name><surname>East</surname><given-names>S</given-names></name><name><surname>Mitra</surname><given-names>S</given-names></name><name><surname>Jansen</surname><given-names>LET</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>p97/VCP drives turnover of SUMOylated centromeric CCAN proteins and CENP-A</article-title><source>Molecular Biology of the Cell</source><volume>34</volume><elocation-id>br6</elocation-id><pub-id pub-id-type="doi">10.1091/mbc.E23-01-0035</pub-id><pub-id pub-id-type="pmid">36989032</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Boom</surname><given-names>J</given-names></name><name><surname>Wolf</surname><given-names>M</given-names></name><name><surname>Weimann</surname><given-names>L</given-names></name><name><surname>Schulze</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Kaschani</surname><given-names>F</given-names></name><name><surname>Riemer</surname><given-names>A</given-names></name><name><surname>Zierhut</surname><given-names>C</given-names></name><name><surname>Kaiser</surname><given-names>M</given-names></name><name><surname>Iliakis</surname><given-names>G</given-names></name><name><surname>Funabiki</surname><given-names>H</given-names></name><name><surname>Meyer</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>VCP/p97 extracts sterically trapped Ku70/80 rings from DNA in double-strand break repair</article-title><source>Molecular Cell</source><volume>64</volume><fpage>189</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.08.037</pub-id><pub-id pub-id-type="pmid">27716483</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Heijden</surname><given-names>GW</given-names></name><name><surname>Derijck</surname><given-names>AAHA</given-names></name><name><surname>Pósfai</surname><given-names>E</given-names></name><name><surname>Giele</surname><given-names>M</given-names></name><name><surname>Pelczar</surname><given-names>P</given-names></name><name><surname>Ramos</surname><given-names>L</given-names></name><name><surname>Wansink</surname><given-names>DG</given-names></name><name><surname>van der Vlag</surname><given-names>J</given-names></name><name><surname>Peters</surname><given-names>AHFM</given-names></name><name><surname>de Boer</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Chromosome-wide nucleosome replacement and H3.3 incorporation during mammalian meiotic sex chromosome inactivation</article-title><source>Nature Genetics</source><volume>39</volume><fpage>251</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1038/ng1949</pub-id><pub-id pub-id-type="pmid">17237782</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varet</surname><given-names>H</given-names></name><name><surname>Brillet-Guéguen</surname><given-names>L</given-names></name><name><surname>Coppée</surname><given-names>JY</given-names></name><name><surname>Dillies</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SARTools: A DESeq2- and EdgeR-Based R pipeline for comprehensive differential analysis of RNA-seq data</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0157022</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0157022</pub-id><pub-id pub-id-type="pmid">27280887</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Perazza</surname><given-names>D</given-names></name><name><surname>Boussouar</surname><given-names>F</given-names></name><name><surname>Cattaneo</surname><given-names>M</given-names></name><name><surname>Bougdour</surname><given-names>A</given-names></name><name><surname>Chuffart</surname><given-names>F</given-names></name><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Vargas</surname><given-names>A</given-names></name><name><surname>Liakopoulou</surname><given-names>A</given-names></name><name><surname>Puthier</surname><given-names>D</given-names></name><name><surname>Bargier</surname><given-names>L</given-names></name><name><surname>Morozumi</surname><given-names>Y</given-names></name><name><surname>Jamshidikia</surname><given-names>M</given-names></name><name><surname>Garcia-Saez</surname><given-names>I</given-names></name><name><surname>Petosa</surname><given-names>C</given-names></name><name><surname>Rousseaux</surname><given-names>S</given-names></name><name><surname>Verdel</surname><given-names>A</given-names></name><name><surname>Khochbin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>ATAD2 controls chromatin-bound HIRA turnover</article-title><source>Life Science Alliance</source><volume>4</volume><elocation-id>e202101151</elocation-id><pub-id pub-id-type="doi">10.26508/lsa.202101151</pub-id><pub-id pub-id-type="pmid">34580178</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuen</surname><given-names>BTK</given-names></name><name><surname>Bush</surname><given-names>KM</given-names></name><name><surname>Barrilleaux</surname><given-names>BL</given-names></name><name><surname>Cotterman</surname><given-names>R</given-names></name><name><surname>Knoepfler</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Histone H3.3 regulates dynamic chromatin states during spermatogenesis</article-title><source>Development</source><volume>141</volume><fpage>3483</fpage><lpage>3494</lpage><pub-id pub-id-type="doi">10.1242/dev.106450</pub-id><pub-id pub-id-type="pmid">25142466</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107582.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dalal</surname><given-names>Yamini</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>National Cancer Institute</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>This <bold>valuable</bold> study explores the role of the chromatin regulator ATAD2 in mouse spermatogenesis. The data <bold>convincingly</bold> demonstrate that ATAD2 is essential for proper chromatin remodeling in haploid spermatids, influencing gene accessibility, H3.3-mediated transcription, and histone eviction. Using Atad2 knockout (KO) mice, the authors link ATAD2 to the DNA-replication-independent incorporation of sperm-specific proteins like protamines and histone H3.3. Although the findings highlight chromatin abnormalities and impaired in vitro fertilization in KO mice, natural fertility remains unaffected, suggesting possible in vivo compensatory mechanisms. Future experiments will be needed to tease out the precise molecular role of ATAD2 in spermatogenesis. This work will be of interest to the epigenetics and developmental fields.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107582.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The authors analyzed the expression of ATAD2 protein in post-meiotic stages and characterized the localization of various testis-specific proteins in the testis of the Atad2 knockout (KO). By cytological analysis as well as the ATAC sequencing, the study showed that increased levels of HIRA histone chaperone, accumulation of histone H3.3 on post-meiotic nuclei, defective chromatin accessibility and also delayed deposition of protamines. Sperm from the Atad2 KO mice reduces the success of in vitro fertilization. The work was performed well, and most of the results are convincing. However, this manuscript does not suggest a molecular mechanism for how ATAD2 promotes the formation of testis-specific chromatin.</p><p>Strengths:</p><p>The paper describes the role of ATAD2 AAA+ ATPase in the proper localization of sperm-specific chromatin proteins such as protamine, suggesting the importance of the DNA replication-independent histone exchanges with the HIRA-histone H3.3 axis.</p><p>Weaknesses:</p><p>The work was performed well, and most of the results are convincing. However, this manuscript does not suggest a molecular mechanism for how ATAD2 promotes the formation of testis-specific chromatin.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107582.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This manuscript by Liakopoulou et al. presents a comprehensive investigation into the role of ATAD2 in regulating chromatin dynamics during spermatogenesis. The authors elegantly demonstrate that ATAD2, via its control of histone chaperone HIRA turnover, ensures proper H3.3 localization, chromatin accessibility, and histone-to-protamine transition in post-meiotic male germ cells. Using a new well-characterized Atad2 KO mouse model, they show that ATAD2 deficiency disrupts HIRA dynamics, leading to aberrant H3.3 deposition, impaired transcriptional regulation, delayed protamine assembly, and defective sperm genome compaction. The study bridges ATAD2's conserved functions in embryonic stem cells and cancer to spermatogenesis, revealing a novel layer of epigenetic regulation critical for male fertility.</p><p>Strengths:</p><p>The MS first demonstration of ATAD2's essential role in spermatogenesis, linking its expression in haploid spermatids to histone chaperone regulation by connecting ATAD2-dependent chromatin dynamics to gene accessibility (ATAC-seq), H3.3-mediated transcription, and histone eviction. Interestingly and surprisingly, sperm chromatin defects in Atad2 KO mice impair only in vitro fertilization but not natural fertility, suggesting unknown compensatory mechanisms in vivo.</p><p>Weaknesses:</p><p>The MS is robust and there are not big weaknesses</p><p>The authors have addressed all the queries successfully.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107582.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The authors generated knockout mice for Atad2, a conserved bromodomain-containing factor expressed during spermatogenesis. In Atad2 KO mice, HIRA, a chaperone for histone variant H3.3, was upregulated in round spermatids, accompanied by an apparent increase in H3.3 levels. Furthermore, the sequential incorporation and removal of TH2B and PRM1 during spermiogenesis were partially disrupted in the absence of ATAD2, possibly due to delayed histone removal. Despite these abnormalities, Atad2 KO male mice were able to produce offspring normally.</p><p>Strengths:</p><p>The manuscript addresses the biological role of ATAD2 in spermatogenesis using a knockout mouse model, providing a valuable in vivo framework to study chromatin regulation during male germ cell development. The observed redistribution of H3.3 in round spermatids is clearly presented and suggests a previously unappreciated role of ATAD2 in histone variant dynamics. The authors also document defects in the sequential incorporation and removal of TH2B and PRM1 during spermiogenesis, providing phenotypic insight into chromatin transitions in late spermatogenic stages. Overall, the study presents a solid foundation for further mechanistic investigation into ATAD2 function.</p><p>Weaknesses:</p><p>While the manuscript reports the gross phenotype of Atad2 KO mice, the findings remain largely superficial and do not convincingly demonstrate how ATAD2 deficiency affects chromatin.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.107582.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liakopoulou</surname><given-names>Ariadni</given-names></name><role specific-use="author">Author</role><aff><institution>Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences</institution><addr-line><named-content content-type="city">Grenoble</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Boussouar</surname><given-names>Faycal</given-names></name><role specific-use="author">Author</role><aff><institution>Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences</institution><addr-line><named-content content-type="city">Grenoble</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Perazza</surname><given-names>Daniel</given-names></name><role specific-use="author">Author</role><aff><institution>Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences</institution><addr-line><named-content content-type="city">Grenoble</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Barral</surname><given-names>Sophie</given-names></name><role specific-use="author">Author</role><aff><institution>Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences</institution><addr-line><named-content content-type="city">Grenoble</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Lambert</surname><given-names>Emeline</given-names></name><role specific-use="author">Author</role><aff><institution>INSERM, CNRS, University Grenoble-Alpes</institution><addr-line><named-content content-type="city">Grenoble</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Tao</given-names></name><role specific-use="author">Author</role><aff><institution>Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences</institution><addr-line><named-content content-type="city">Grenoble</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Chuffart</surname><given-names>Florent</given-names></name><role specific-use="author">Author</role><aff><institution>Université Grenoble</institution><addr-line><named-content content-type="city">Grenoble</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Bourova-Flin</surname><given-names>Ekaterina</given-names></name><role specific-use="author">Author</role><aff><institution>Université Grenoble</institution><addr-line><named-content content-type="city">Grenoble</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Gard</surname><given-names>Charlyne</given-names></name><role specific-use="author">Author</role><aff><institution>Aix Marseille Université, INSERM, UMR U1090, TAGC</institution><addr-line><named-content content-type="city">Marseille</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Puthier</surname><given-names>Denis</given-names></name><role specific-use="author">Author</role><aff><institution>Aix Marseille Université, INSERM, UMR U1090, TAGC,</institution><addr-line><named-content content-type="city">Marseille</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Rousseaux</surname><given-names>Sophie</given-names></name><role specific-use="author">Author</role><aff><institution>Université Grenoble</institution><addr-line><named-content content-type="city">Grenoble</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Arnoult</surname><given-names>Christophe</given-names></name><role specific-use="author">Author</role><aff><institution>Université Grenoble Alpes</institution><addr-line><named-content content-type="city">Grenoble</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Verdel</surname><given-names>André</given-names></name><role specific-use="author">Author</role><aff><institution>Institute for Advanced Biosciences</institution><addr-line><named-content content-type="city">Grenoble</named-content></addr-line><country>France</country></aff></contrib><contrib contrib-type="author"><name><surname>Khochbin</surname><given-names>Saadi</given-names></name><role specific-use="author">Author</role><aff><institution>Université Grenoble</institution><addr-line><named-content content-type="city">Grenoble</named-content></addr-line><country>France</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews:</bold></p><p><bold>Reviewer #1 (Public review):</bold></p><p>Summary:</p><p>The authors analyzed the expression of ATAD2 protein in post-meiotic stages and characterized the localization of various testis-specific proteins in the testis of the Atad2 knockout (KO). By cytological analysis as well as the ATAC sequencing, the study showed that increased levels of HIRA histone chaperone, accumulation of histone H3.3 on post-meiotic nuclei, defective chromatin accessibility and also delayed deposition of protamines. Sperm from the Atad2 KO mice reduces the success of in vitro fertilization. The work was performed well, and most of the results are convincing. However, this manuscript does not suggest a molecular mechanism for how ATAD2 promotes the formation of testis-specific chromatin.</p></disp-quote><p>We would like to take this opportunity to highlight that the present study builds on our previously published work, which examined the function of ATAD2 in both yeast <italic>S. pombe</italic> and mouse embryonic stem (ES) cells (Wang et al., 2021). In yeast, using genetic analysis we showed that inactivation of HIRA rescues defective cell growth caused by the absence of ATAD2. This rescue could also be achieved by reducing histone dosage, indicating that the toxicity depends on histone over-dosage, and that HIRA toxicity, in the absence of ATAD2, is linked to this imbalance.</p><p>Furthermore, HIRA ChIP-seq performed in mouse ES cells revealed increased nucleosome-bound HIRA, particularly around transcription start sites (TSS) of active genes, along with the appearance of HIRA-bound nucleosomes within normally nucleosome-free regions (NFRs). These findings pointed to ATAD2 as a major factor responsible for unloading HIRA from nucleosomes. This unloading function may also apply to other histone chaperones, such as FACT (see Wang et al., 2021, Fig. 4C).</p><p>In the present study, our investigations converge on the same ATAD2 function in the context of a physiologically integrated mammalian system—spermatogenesis. Indeed, in the absence of ATAD2, we observed H3.3 accumulation and enhanced H3.3-mediated gene expression. Consistent with this functional model of ATAD2— unloading chaperones from histone- and non-histone-bound chromatin—we also observed defects in histone-toprotamine replacement.</p><p>Together, the results presented here and in Wang et al. (2021) reveal an underappreciated regulatory layer of histone chaperone activity. Previously, histone chaperones were primarily understood as factors that load histones. Our findings demonstrate that we must also consider a previously unrecognized regulatory mechanism that controls assembled histone-bound chaperones. This key point was clearly captured and emphasized by Reviewer #2 (see below).</p><disp-quote content-type="editor-comment"><p>Strengths:</p><p>The paper describes the role of ATAD2 AAA+ ATPase in the proper localization of sperm-specific chromatin proteins such as protamine, suggesting the importance of the DNA replication-independent histone exchanges with the HIRA-histone H3.3 axis.</p><p>Weaknesses:</p><p>(1) Some results lack quantification.</p></disp-quote><p>We will consider all the data and add appropriate quantifications where necessary.</p><disp-quote content-type="editor-comment"><p>(2) The work was performed well, and most of the results are convincing. However, this manuscript does not suggest a molecular mechanism for how ATAD2 promotes the formation of testis-specific chromatin.</p></disp-quote><p>Please see our comments above.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>Summary:</p><p>This manuscript by Liakopoulou et al. presents a comprehensive investigation into the role of ATAD2 in regulating chromatin dynamics during spermatogenesis. The authors elegantly demonstrate that ATAD2, via its control of histone chaperone HIRA turnover, ensures proper H3.3 localization, chromatin accessibility, and histone-toprotamine transition in post-meiotic male germ cells. Using a new well-characterized Atad2 KO mouse model, they show that ATAD2 deficiency disrupts HIRA dynamics, leading to aberrant H3.3 deposition, impaired transcriptional regulation, delayed protamine assembly, and defective sperm genome compaction. The study bridges ATAD2's conserved functions in embryonic stem cells and cancer to spermatogenesis, revealing a novel layer of epigenetic regulation critical for male fertility.</p><p>Strengths:</p><p>The MS first demonstration of ATAD2's essential role in spermatogenesis, linking its expression in haploid spermatids to histone chaperone regulation by connecting ATAD2-dependent chromatin dynamics to gene accessibility (ATAC-seq), H3.3-mediated transcription, and histone eviction. Interestingly and surprisingly, sperm chromatin defects in Atad2 KO mice impair only in vitro fertilization but not natural fertility, suggesting unknown compensatory mechanisms in vivo.</p><p>Weaknesses:</p><p>The MS is robust and there are not big weaknesses</p><p><bold>Reviewer #3 (Public review):</bold></p><p>Summary:</p><p>The authors generated knockout mice for Atad2, a conserved bromodomain-containing factor expressed during spermatogenesis. In Atad2 KO mice, HIRA, a chaperone for histone variant H3.3, was upregulated in round spermatids, accompanied by an apparent increase in H3.3 levels. Furthermore, the sequential incorporation and removal of TH2B and PRM1 during spermiogenesis were partially disrupted in the absence of ATAD2, possibly due to delayed histone removal. Despite these abnormalities, Atad2 KO male mice were able to produce offspring normally.</p><p>Strengths:</p><p>The manuscript addresses the biological role of ATAD2 in spermatogenesis using a knockout mouse model, providing a valuable in vivo framework to study chromatin regulation during male germ cell development. The observed redistribution of H3.3 in round spermatids is clearly presented and suggests a previously unappreciated role of ATAD2 in histone variant dynamics. The authors also document defects in the sequential incorporation and removal of TH2B and PRM1 during spermiogenesis, providing phenotypic insight into chromatin transitions in late spermatogenic stages. Overall, the study presents a solid foundation for further mechanistic investigation into ATAD2 function.</p><p>Weaknesses:</p><p>While the manuscript reports the gross phenotype of Atad2 KO mice, the findings remain largely superficial and do not convincingly demonstrate how ATAD2 deficiency affects chromatin dynamics. Moreover, the phenotype appears too mild to elucidate the functional significance of ATAD2 during spermatogenesis.</p></disp-quote><p>We respectfully disagree with the statement that our findings are largely superficial. Based on our investigations of this factor over the years, it has become evident that ATAD2 functions as an auxiliary factor that facilitates mechanisms controlling chromatin dynamics (see, for example, Morozumi et al., 2015). These mechanisms can still occur in the absence of ATAD2, but with reduced efficiency, which explains the mild phenotype we observed.</p><p>This function, while not essential, is nonetheless an integral part of the cell’s molecular biology and should be studied and brought to the attention of the broader biological community, just as we study essential factors. Unfortunately, the field has tended to focus primarily on core functional actors, often overlooking auxiliary factors. As a result, our decade-long investigations into the subtle yet important roles of ATAD2 have repeatedly been met with skepticism regarding its functional significance, which has in turn influenced editorial decisions.</p><p>We chose eLife as the venue for this work specifically to avoid such editorial barriers and to emphasize that facilitators of essential functions do exist. They deserve to be investigated, and the underlying molecular regulatory mechanisms must be understood.</p><disp-quote content-type="editor-comment"><p>(1) Figures 4-5: The analyses of differential gene expression and chromatin organization should be more comprehensive. First, Venn diagrams comparing the sets of significantly differentially expressed genes between this study and previous work should be shown for each developmental stage. Second, given the established role of H3.3 in MSCI, the effect of Atad2 knockout on sex chromosome gene expression should be analyzed. Third, integrated analysis of RNA-seq and ATAC-seq data is needed to evaluate how ATAD2 loss affects gene expression. Finally, H3.3 ChIP-seq should be performed to directly assess changes in H3.3 distribution following Atad2 knockout.</p></disp-quote><p>(1) In the revised version, we will include Venn diagrams to illustrate the overlap in significantly differentially expressed genes between this study and previous work. However, we believe that the GSEAs presented here provide stronger evidence, as they indicate the statistical significance of this overlap (p-values). In our case, we observed p-value &lt; 0.01 (**) and p &lt; 0.001 (<bold>***</bold>).</p><p>(2) Sex chromosome gene expression was analyzed and is presented in Fig. 5C.</p><p>(3) The effect of ATAD2 loss on gene expression is shown in Fig. 4A, B, and C as histograms, with statistical significance indicated in the middle panels.</p><p>(4) Although mapping H3.3 incorporation across the genome in wild-type and Atad2 KO cells would have been informative, the available anti-H3.3 antibody did not work for ChIP-seq, at least in our hands. The authors of Fontaine et al., 2022, who studied H3.3 during spermatogenesis in mice, must have encountered the same problem, since they tagged the endogenous H3.3 gene to perform their ChIP experiments.</p><disp-quote content-type="editor-comment"><p>(2) Figure 3: The altered distribution of H3.3 is compelling. This raises the possibility that histone marks associated with H3.3 may also be affected, although this has not been investigated. It would therefore be important to examine the distribution of histone modifications typically associated with H3.3. If any alterations are observed, ChIP-seq analyses should be performed to explore them further.</p></disp-quote><p>Based on our understanding of ATAD2’s function—specifically its role in releasing chromatin-bound HIRA—in the absence of ATAD2 the residence time of both HIRA and H3.3 on chromatin increases. This results in the detection of H3.3 not only on sex chromosomes but across the genome. Our data provide clear evidence of this phenomenon. The reviewer is correct in suggesting that the accumulated H3.3 would carry H3.3-associated histone PTMs; however, we are unsure what additional insights could be gained by further demonstrating this point.</p><disp-quote content-type="editor-comment"><p>(3) Figure 7: While the authors suggest that pre-PRM2 processing is impaired in Atad2 KO, no direct evidence is provided. It is essential to conduct acid-urea polyacrylamide gel electrophoresis (AU-PAGE) followed by western blotting, or a comparable experiment, to substantiate this claim.</p></disp-quote><p>Figure 7 does not suggest that pre-PRM2 processing is affected in Atad2 KO; rather, this figure—particularly Fig. 7B—specifically demonstrates that pre-PRM2 processing is impaired, as shown using an antibody that recognizes the processed portion of pre-PRM2. ELISA was used to provide a more quantitative assessment; however, in the revised manuscript we will also include a western blot image.</p><disp-quote content-type="editor-comment"><p>(4) HIRA and ATAD2: Does the upregulation of HIRA fully account for the phenotypes observed in Atad2 KO? If so, would overexpression of HIRA alone be sufficient to phenocopy the Atad2 KO phenotype? Alternatively, would partial reduction of HIRA (e.g., through heterozygous deletion) in the Atad2 KO background be sufficient to rescue the phenotype?</p></disp-quote><p>These are interesting experiments that require the creation of appropriate mouse models, which are not currently available.</p><disp-quote content-type="editor-comment"><p>(5) The mechanism by which ATAD2 regulates HIRA turnover on chromatin and the deposition of H3.3 remains unclear from the manuscript and warrants further investigation.</p></disp-quote><p>The Reviewer is absolutely correct. In addition to the points addressed in response to Reviewer #1’s general comments (see above), it would indeed have been very interesting to test the segregase activity of ATAD2 (likely driven by its AAA ATPase activity) through in vitro experiments using the Xenopus egg extract system described by Tagami et al., 2004. This system can be applied both in the presence and absence (via immunodepletion) of ATAD2 and would also allow the use of ATAD2 mutants, particularly those with inactive AAA ATPase or bromodomains. However, such experiments go well beyond the scope of this study, which focuses on the role of ATAD2 in chromatin dynamics during spermatogenesis.</p><p>References:</p><p>(1) Wang T, Perazza D, Boussouar F, Cattaneo M, Bougdour A, Chuffart F, Barral S, Vargas A, Liakopoulou A, Puthier D, Bargier L, Morozumi Y, Jamshidikia M, Garcia-Saez I, Petosa C, Rousseaux S, Verdel A, Khochbin S. ATAD2 controls chromatin-bound HIRA turnover. Life Sci Alliance. 2021 Sep 27;4(12):e202101151. doi: 10.26508/lsa.202101151. PMID: 34580178; PMCID: PMC8500222.</p><p>(2) Morozumi Y, Boussouar F, Tan M, Chaikuad A, Jamshidikia M, Colak G, He H, Nie L, Petosa C, de Dieuleveult M, Curtet S, Vitte AL, Rabatel C, Debernardi A, Cosset FL, Verhoeyen E, Emadali A, Schweifer N, Gianni D, Gut M, Guardiola P, Rousseaux S, Gérard M, Knapp S, Zhao Y, Khochbin S. Atad2 is a generalist facilitator of chromatin dynamics in embryonic stem cells. J Mol Cell Biol. 2016 Aug;8(4):349-62. doi: 10.1093/jmcb/mjv060. Epub 2015 Oct 12. PMID: 26459632; PMCID: PMC4991664.</p><p>(3) Fontaine E, Papin C, Martinez G, Le Gras S, Nahed RA, Héry P, Buchou T, Ouararhni K, Favier B, Gautier T, Sabir JSM, Gerard M, Bednar J, Arnoult C, Dimitrov S, Hamiche A. Dual role of histone variant H3.3B in spermatogenesis: positive regulation of piRNA transcription and implication in X-chromosome inactivation. Nucleic Acids Res. 2022 Jul 22;50(13):7350-7366. doi: 10.1093/nar/gkac541. PMID: 35766398; PMCID: PMC9303386.</p><p>(4) Tagami H, Ray-Gallet D, Almouzni G, Nakatani Y. Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell. 2004 Jan 9;116(1):51-61. doi: 10.1016/s0092-8674(03)01064-x. PMID: 14718166.</p><disp-quote content-type="editor-comment"><p><bold>Recommendations for the authors:</bold></p><p><bold>Reviewing Editor Comments:</bold></p><p>I note that the reviewers had mixed opinions about the strength of the evidence in the manuscript. A revision that addresses these points would be welcome.</p><p><bold>Reviewer #1 (Recommendations for the authors):</bold></p><p>Major points:</p><p>(1) No line numbers: It is hard to point out the issues.</p></disp-quote><p>The revised version harbors line numbers.</p><disp-quote content-type="editor-comment"><p>(2) Given the results shown in Figure 3 and Figure 4, it is nice to show the chromosomal localization of histone H3.3 in spermatocytes or post-meiotic cells by Chromatin-immunoprecipitation sequencing (ChIP-seq).</p></disp-quote><p>Although mapping H3.3 incorporation across the genome in wild-type and Atad2 KO cells would have been informative, the available anti-H3.3 antibody did not work for ChIP-seq in our hands. In fact, this antibody is not well regarded for ChIP-seq. For example, Fontaine et al. (2022), who investigated H3.3 during spermatogenesis in mice, circumvented this issue by tagging the endogenous H3.3 genes for their ChIP experiments.</p><disp-quote content-type="editor-comment"><p>(3) Figure 7B and 8: Why the authors used ELISA for the protein quantification. At least, western blotting should be shown.</p></disp-quote><p>ELISA is a more quantitative method than traditional immunoblotting. Nevertheless, as requested by the reviewer, we have now included a corresponding western blot in Fig. S3.</p><disp-quote content-type="editor-comment"><p>(4) For readers, please add a schematic pathway of histone-protamine replacement in sperm formation in Fig.1 and it would be nice to have a model figure, which contains the authors' idea in the last figure.</p></disp-quote><p>As requested by this reviewer, we have now included a schematic model in Figure 9 to summarize the main conclusions of our work.</p><disp-quote content-type="editor-comment"><p>Minor points:</p><p>(1) Page 2, the second paragraph, &quot;pre-PRM2: Please explain more about pre-PRM2 and/or PRM2 as well as PRM1 (Figure 6).</p></disp-quote><p>More detailed descriptions of PRM2 processing are now given in this paragraph.</p><disp-quote content-type="editor-comment"><p>(2) Page 3, bottom paragraph, line 1: &quot;KO&quot; should be &quot;knockout (KO)&quot;.</p></disp-quote><p>Done.</p><disp-quote content-type="editor-comment"><p>(3) Page 4, second paragraph bottom: Please explain more about the protein structure of germ-line-specific ATAD2S: how it is different from ATAD2L. Germ-line specific means it is also expressed in ovary?</p></disp-quote><p>As Atad2 is predominantly expressed in embryonic stem cells and in spermatogenic cells, we replaced all through the text germ-line specific by more appropriate terms.</p><disp-quote content-type="editor-comment"><p>(4) Figure 1C, western blotting: Wild-type testis extracts, both ATAD2L and -S are present. Does this mean that ATADS2L is expressed in both germ line as well as supporting cells. Please clarify this and, if possible, show the western blotting of spermatids well as spermatocytes.</p></disp-quote><p>Figure 1D shows sections of seminiferous tubules from Atad2 KO mice, in which lacZ expression is driven by the endogenous Atad2 promoter. The results indicate that Atad2 is expressed mainly in post-meiotic cells. Most labeled cells are located near the lumen, whereas the supporting Sertoli cells remain unlabeled. Sertoli cells, which are anchored to the basal lamina, span the entire thickness of the germinal epithelium from the basal lamina to the lumen. Their nuclei, however, are usually positioned closer to the basal membrane. Thus, the observed lacZ expression pattern argues against substantial Atad2 expression in Sertoli cells.</p><disp-quote content-type="editor-comment"><p>(5) Figure 1C: Please explain a bit more about the reduction of ATAD2 proteins in heterozygous mice.</p></disp-quote><p>Done</p><disp-quote content-type="editor-comment"><p>(6) Figure 1C: Genotypes of the mice should be shown in the legend.</p></disp-quote><p>Done</p><disp-quote content-type="editor-comment"><p>(7) Figure 1D: Please add a more magnified image of the sections to see the staining pattern in the seminiferous tubules.</p></disp-quote><p>The magnification does not bring more information since we lose the structure of cells within tubules due the nature of treatment of the sections for X-gal staining. Please see comments to question 1C to reviewer 2</p><disp-quote content-type="editor-comment"><p>(8) Page 5, first paragraph, line 2, histone dosage: What do the authors meant by the histone dosage? Please explain more or use more appropriate word.</p></disp-quote><p>&quot;Histone dosage&quot; refers to the amount or relative abundance of histone proteins in a cell.</p><disp-quote content-type="editor-comment"><p>(9) Figure 2A: Figure 2A: Given the result in Figure 1C, it is interesting to check the amount of HIRA in Atad2 heterozygous mice.</p></disp-quote><p>In Atad2 heterozygous mice, we would expect an increase in HIRA, but only to about half the level seen in the Atad2 homozygous knockout shown in Figure 2A, which is relatively modest. Therefore, we doubt that detecting such a small change—approximately half of that in Figure 2A—would yield clear or definitive results.</p><disp-quote content-type="editor-comment"><p>(10) Figure 2A, legend (n=5): What does this &quot;n&quot; mean? The extract of testes from &quot;5&quot; male mice like Figure 2B. Or 5 independent experiments. If the latter is true, it is important to share the other results in the Supplements.</p></disp-quote><p>“n” refers to five WT and five Atad2 KO males. The legend has been clarified as suggested by the reviewer.</p><disp-quote content-type="editor-comment"><p>(11) Figure 2A, legend, line 2, Atad2: This should be italicized.</p></disp-quote><p>Done</p><disp-quote content-type="editor-comment"><p>(12) Figure 2B: Please show the quantification of amounts of HIRA protein like Fig. 2A.</p></disp-quote><p>As indicated in the legend, what is shown is a pool of testes from 3 individuals per genotype.</p><disp-quote content-type="editor-comment"><p>(13) Figure 2B shows an increased level of HIRA in Atad2 KO testis. This suggests the role of ATAD2 in the protein degradation of HIRA. This possibility should be mentioned or tested since ATAD2 is an AAA+ ATPase.</p></disp-quote><p>The extensive literature on ATAD2 provides no indication that it is involved in protein degradation. In our early work on ATAD2 in the 2000s, we hypothesized that, as a member of the AAA ATPase family, ATAD2 might associate with the 19S proteasome subunit (through multimerization with the other AAA ATPase member of this regulatory subunit). However, both our published pilot studies (Caron et al., PMID: 20581866) and subsequent unpublished work ruled out this possibility. Instead, since the amount of nucleosome-bound HIRA increases in the absence of ATAD2, we propose that chromatin-bound HIRA is more stable than soluble HIRA once it has been released from chromatin by ATAD2.</p><disp-quote content-type="editor-comment"><p>(14) Page 6, second paragraph, line 5, ko: KO should be capitalized.</p></disp-quote><p>Done</p><disp-quote content-type="editor-comment"><p>(15) Page 6, second paragraph, line 2 from the bottom, chromatin dynamics: Throughout the text, the authors used &quot;chromatin dynamics&quot;. However, all the authors analyzed in the current study is the localization of chromatin protein. So, it is much easier to explain the results by using &quot;chromatin status,&quot; etc. In this context, &quot;accessibility&quot; is better.</p></disp-quote><p>We changed the term “chromatin dynamics” into a more precise term according to the context used all through the text.</p><disp-quote content-type="editor-comment"><p>(16) Figure 3: Please provide the quantification of signals of histone H3.3 in a nucleus or nuclear cytoplasm.</p></disp-quote><p>This request is not clear to us since we do not observe any H3.3 signal in the cytoplasm.</p><disp-quote content-type="editor-comment"><p>(17) Figure 3: As the control of specificity in post-meiotic cells, please show the image and quantification of the H3.3 signals in spermatocyte, for example.</p></disp-quote><p>This request is not clear to us. What specificity is meant?</p><disp-quote content-type="editor-comment"><p>(18) Figure 3, bottom panels: Please show what the white lines indicate?</p></disp-quote><p>The white lines indicate the limit of cell nucleus and estimated by Hoechst staining. This is now indicated in the legend of the figure.</p><disp-quote content-type="editor-comment"><p>(19) Figure 4A: Please explain more about what kind of data is here. Is this wild-type and/or Atad2 KO? The label of the Y-axis should be &quot;mean expression level&quot;. What is the standard deviation (SD) here on the X-axis. Moreover, there is only one red open circle, but the number of this class is 5611. All 5611 genes in this group show NO expression. Please explain more.</p></disp-quote><p>The plot displays the mean expression levels (y-axis, labeled as &quot;mean expression level&quot;) versus the corresponding standard deviations (x-axis), both calculated from three independent biological replicates of isolated round spermatids (Atad2 wild-type and Atad2 KO). The standard deviation reflects the variability of gene expression across biological replicates. Genes were grouped into four categories (grp1: blue, grp2: cyan, grp3: green, grp4: orange) according to the quartile of their mean expression. For grp4, all genes have no detectable expression, resulting in a mean expression of zero and a standard deviation of zero; consequently, the 5611 genes in this group are represented by a single overlapping point (red open circle) at the origin.</p><disp-quote content-type="editor-comment"><p>(20) Figure 4C: If possible, it would be better to have a statistical comparison between wild-type and the KO.</p></disp-quote><p>The mean profiles are displayed together with their variability (± 2 s.e.m.) across the four replicates for both ATAD2 WT (blue) and ATAD2 KO (red). For groups 1, 2, and 3, the envelopes of the curves remain clearly separated around the peak, indicating a consistent difference in signal between the two conditions. In contrast, group 4 does not present a strong signal and, accordingly, no marked difference is observed between WT and KO in this group.</p><disp-quote content-type="editor-comment"><p>(21) Figure 5, GSEA panels: Please explain more about what the GSEA is in the legend. The legend has been updated as follows:</p></disp-quote><p>(A) Expression profiles of post-meiotic H3.3-activated genes. The heatmap (left panel) displays the normalized expression levels of genes identified by Fontaine and colleagues as upregulated in the absence of histone H3.3 (Fontaine et al. 2022) for Atad2 WT (WT) and Atad2 KO (KO) samples at days 20, 22, 24, and 26 PP (D20 to D26). The colour scale represents the z-score of log-transformed DESeq2-normalized counts. The middle panel box plots display, pooled, normalized expression levels, aggregated across replicates and genes, for each condition (WT and KO) and each time point (D20 to D26). Statistical significance between WT and KO conditions was determined using a two-sided t-test, with p-values indicated as follows: * for p-value&lt;0.05, ** for p-value&lt;0.01 and *** for p-value&lt;0.001. The right panel shows the results of gene set enrichment analysis (GSEA), which assesses whether predefined groups of genes show statistically significant differences between conditions. Here, the post-meiotic H3.3-activated genes set, identified by Fontaine et al. (2022), is significantly enriched in Atad2 KO compared with WT samples at day 26 (p &lt; 0.05, FDR &lt; 0.25). Coloured vertical bars indicate the “leading edge” genes (i.e., those contributing most to the enrichment signal), located before the point of maximum enrichment score. (B) As shown in (A) but for the &quot;post-meiotic H3.3-repressed genes&quot; gene set. (C) As shown in (A) but for the &quot; sex chromosome-linked genes &quot; gene set.</p><disp-quote content-type="editor-comment"><p>(22) Figure 6. In the KO, the number of green cells is more than red and yellow cells, suggesting the delayed maturation of green (TH2B-positive) cells. It is essential to count the number of each cell and show the quantification.</p></disp-quote><p>The green cells correspond to those expressing TH2B but lacking transition proteins (TP) and protamine 1 (Prm1), indicating that they are at earlier stages than elongating–condensing spermatids. Counting these green cells simply reflects the ratio of elongating/condensing spermatids to earlier-stage cells, which varies depending on the field examined. The key point in this experiment is that in wild-type mice, only red cells (elongating/condensing spermatids) and green cells (earlier stages) are observed. By contrast, in Atad2 KO testes, a significant proportion of yellow cells appears, which are never seen in wild-type tissue. The crucial metric here is the percentage of yellow cells relative to the total number of elongating/condensing spermatids (red cells). In wild-type testes, this value is consistently 0%, whereas in Atad2 KO testes it always ranges between 50% and 100% across all fields containing substantial numbers of elongating/condensing spermatids.</p><disp-quote content-type="editor-comment"><p>(23) Figure 8A: Please show the images of sperm (heads) in the KO mice with or without decompaction.</p></disp-quote><p>The requested image is now displayed in Figure S5.</p><disp-quote content-type="editor-comment"><p>(24) Figure 8C: In the legend, it says n=5. However, there are more than 5 plots on the graph. Please explain the experiment more in detail.</p></disp-quote><p>The experiment is now better explained in the legend of this Figure.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations for the authors):</bold></p><p>While the study is rigorous and well performed, the following minor points could be addressed to strengthen the manuscript:</p><p>Figure 1C should indicate each of the different types of cells present in the sections. It would be of interest to show specifically the different post-meiotic germ cells.</p></disp-quote><p>With this type of sample preparation, it is difficult to precisely distinguish the different cell types within the sections. Nevertheless, the staining pattern strongly indicates that most of the intensely stained cells are post-meiotic, situated near the tubule lumens and extending roughly halfway toward the basal membrane.</p><disp-quote content-type="editor-comment"><p>In the absence of functional ATAD2, the accumulation of HIRA primarily occurs in round spermatids (Fig. 2B). If technically possible, it would be of great interest to show this by IHC of testis section.</p></disp-quote><p>Unfortunately, our antibody did not satisfactorily work in IHC.</p><disp-quote content-type="editor-comment"><p>The increased of H3.3 signal in Atad2 KO spermatids (Fig. 3) is interpreted because of a reduced turnover. However, alternative explanations (e.g., H3.3 misincorporation or altered chaperone affinity) should not be ruled out.</p></disp-quote><p>The referee is correct that alternative explanations are possible. However, based on our previous work (Wang et al., 2021; PMID: 34580178), we demonstrated that in the absence of ATAD2, there is reduced turnover of HIRAbound nucleosomes, as well as reduced nucleosome turnover, evidenced by the appearance of nucleosomes in regions that are normally nucleosome-free at active gene TSSs. We have no evidence supporting any other alternative hypothesis.</p><disp-quote content-type="editor-comment"><p>In the MS the reduced accessibility at active genes (Fig. 4) is attributed to H3.3 overloading. However, global changes in histone acetylation (e.g., H4K5ac) or other remodelers in KO cells could be also consider.</p></disp-quote><p>In fact, we meant that histone overloading could be responsible for the altered accessibility. This has been clearly demonstrated in case of <italic>S. cerevisiae</italic> in the absence of Yta7 (<italic>S. cerevisiae</italic>’ ATAD2) (PMID: 25406467).</p><disp-quote content-type="editor-comment"><p>In relation with the sperm compaction assay (Fig. 8A), the DTT/heparin/Triton protocol may not fully reflect physiological decompaction. This could be validated with alternative methods (e.g., MNase sensitivity).</p></disp-quote><p>The referee is right, but since this is a subtle effect as it can be judged by normal fertility, we doubt that milder approaches could reveal significant differences between wildtype and Atad2 KO sperms.</p><disp-quote content-type="editor-comment"><p>It is surprising that despite the observed alterations in the genome organization of the sperm, the natural fertility of the KO mice is not affected (Fig. 8C). This warrants deeper discussion: Is functional compensation occurring (e.g., by p97/VCP)? Analysis of epididymal sperm maturation or uterine environment could provide insights.</p></disp-quote><p>As detailed in the Discussion section, this work, together with our previous study (Wang et al., 2021; PMID: 34580178), highlights an overlooked level of regulation in histone chaperone activity: the release of chromatinbound factors following their interaction with chromatin. This is an energy-dependent process, driven by ATP and the associated ATPase activity of these factors. Such activity could be mediated by various proteins, such as p97/VCP or DNAJC9–HSP70, as discussed in the manuscript, or by yet unidentified factors. However, most of these mechanisms are likely to occur during the extensive histone-to-histone variant exchanges of meiosis and post-meiotic stages. To the best of our knowledge, epididymal sperm maturation and the uterine environment do not involve substantial histone-to-histone or histone-to-protamine exchanges.</p><disp-quote content-type="editor-comment"><p>The authors showed that MSCI genes present an enhancement of repression in the absence of ATAD2 by enhancing H3.3 function. It would be also of interest to analyze the behavior of the Sex body during its silencing (zygotene to pachytene) by looking at different markers (i.e., gamma-H2AX phosphorylation, Ubiquitylation etc).</p></disp-quote><p>The referee is correct that this is an interesting question. Accordingly, in our future work, we plan to examine the sex body in more detail during its silencing, using a variety of relevant markers, including those suggested by the reviewer. However, we believe that such investigations fall outside the scope of the present study, which focuses on the molecular relationship between ATAD2 and H3.3, rather than on the role of H3.3 in regulating sex body transcription. For a comprehensive analysis of this aspect, studies should primarily focus on the H3.3 mouse models reported by Fontaine and colleagues (PMID: 35766398).</p><disp-quote content-type="editor-comment"><p>Fig. 6: Co-staining of TH2B/TP1/PRM1 is convincing but would benefit from quantification (% cells with overlapping signals).</p></disp-quote><p>The green cells correspond to those expressing TH2B but lacking transition proteins (TP) and protamine 1 (Prm1), indicating that they are at earlier stages than elongating–condensing spermatids. Counting these green cells simply reflects the ratio of elongating/condensing spermatids to earlier-stage cells, which varies depending on the field examined. The key point is that in wild-type mice, only red cells (elongating/condensing spermatids) and green cells (earlier stages) are observed. By contrast, in Atad2 KO testes, a significant proportion of yellow cells appears, which are never seen in wild-type tissue. The crucial metric is the percentage of yellow cells relative to the total number of elongating/condensing spermatids (red cells). In wild-type testes, this value is consistently 0%, whereas in Atad2 KO testes it always ranges between 50% and 100% across all fields containing substantial numbers of elongating/condensing spermatids.</p></body></sub-article></article>